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ABSTRACT 
IN SITU ANALYSIS OF LINE-1 PROMOTER ACTIVITY USING LACZ 
TRANSGENIC MICE 
 
PARTHA SARATHI SAHA 
2020 
Apart from an evolutionary role, transposable elements have been implicated in animal 
development and also in pathophysiology. Non-LTR retrotransposons– LINE-1, Alu and 
SVA - are responsible for over 120 cases of human genetic diseases as heritable insertions, 
and are emerging as an important etiological factor for cancer and neurological disorders 
as somatic mutations. It is estimated that among the total number of 500,000 LINE-1s 
presents in the human genome, 80-100 LINE-1s remain competent for retrotransposition. 
Retrotransposition is only possible when LINE-1 is expressed. Because LINE-1 
transcription is regulated by its 5’UTR promoter, it is essential to understand the 
spatiotemporal control of LINE-1 promoter activity. The huge abundance, repetitive nature 
and complex expression patterns of LINE-1s in the human and mouse genomes necessitate 
the development of innovative approaches and the careful design of experimental 
procedures used to study these elements. The primary objective of this dissertation was to 
develop and validate a mouse model, which can be utilized for studying LINE-1 promoter 
activity in vivo. Here, we utilized an in situ staining technique to quantify the endogenous 
LINE-1 promoter activity in different organs of the mouse model - to understand any 
organ-specific regulation of the mouse endogenous LINE-1 promoter activity. Moreover, 
by integrating the transgene into random or specific genomic loci in different orientations, 
we characterized the locus-dependent as well as the orientation-dependent expression 
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patterns. In all these aspects, we attempted to understand LINE-1 promoter regulation 
during different periods of mouse development. Lastly, we also attempted to understand 
the cell-specific regulation, especially in the brain. We reported here organ-specific, age-
linked, locus-associated, and orientation-dependent LINE-1 promoter activities in the 
mouse genome. Out study provides novel insights into LINE-1 biology and the new mouse 











   
Chapter 1  
General Introduction 
 
1.1 Transposable elements 
Transposable elements describe a unique form of DNA that is mobile in the genome. That 
is, transposable elements are sequences that are capable of “jumping” and inserting 
themselves into new genomic contexts. The movement of sequences within the genome 
can generate a genetic variation by creating new sequences, but transposable elements can 
also be disruptive to normal gene function by interrupting gene sequences and producing 
mutations. 
In humans, the majority of transposable elements have lost their ability to jump around the 
genome over evolutionary time, but a few have retained the ability to do so. These 
transposable elements that can still insert themselves elsewhere are often referred to as 
“transposition competent” (Faulkner and Billon, 2018). Transposable elements those have 
lost their ability to jump around the genome have usually done so through acquiring 
mutations that disrupt their activity (Bodak et al., 2014). 
The functions of these transposable elements are sometimes unclear, they were initially 
assumed to be evolutionary remnants of parasitic infection. But more recent evidence 
implicates them in a wide variety of processes, including regulating gene expression 
(Elbarbary et al., 2016), cell identity (Percharde et al., 2018), and promoting genome 
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variation (Richardson et al., 2015). Transposable elements represent almost half of 
mammalian genomes (Belancio et al., 2008).  
Transposable elements move to new locations in the genome by either by transposition (in 
the case of DNA transposons) or retrotransposition (in the case of retrotransposons). 
Transposition is a “cut and paste” mechanism, where the element moves from one region 
to another, and retrotransposition is a “copy and paste” mechanism, where the element first 
makes a copy of itself by reverse transcription and then integrates elsewhere in the genome 
(Faulkner and Billon, 2018). This introductory chapter will discuss recent advances in our 
understanding of the expression and control of LINE-1 elements, an important class of 
retrotransposons and only actively mobile elements in the human genome.  
1.2 LINE-1 elements 
LINE-1 elements are a member of the family of Long INterspersed Elements (LINEs or 
L1s), a family of retrotransposons that are widespread in the mammalian genome, and 
present in the genome of other eukaryotes. Retrotransposons require an RNA intermediate 
to function as transposable elements, and first make a copy of themselves before jumping 
elsewhere in the genome (Boeke et al., 1985). LINE-1 retrotransposons represent a group 
of retrotransposons termed non-long terminal repeat (LTR) retrotransposons, reflecting the 
genetic structure of the elements (Xiong and Eickbush, 1990). 
LINE elements are abundant in eukaryotes and makeup approximately 17.5% and 19.9% 
in the human and mouse genomes, respectively (Lander et al., 2001; Waterston et al., 
2002). While most transposable elements in the mammalian genome are inactive, a small 
percentage (less than 1%) of LINE-1 elements remain capable of mobilization and 
3 
 
   
generating variation in human and mouse genomes (Beck et al., 2011; Faulkner and Garcia-
Perez, 2017; Goodier et al., 2001). This makes LINE-1 elements a unique and important 
class of transposable elements. 
The movement and integration of LINE-1 elements in the genome continue to drive 
evolution (Ostertag and Kazazian, 2001), but to prevent inappropriate LINE-1 expression 
from driving mutagenesis, cells have developed mechanisms of diminishing LINE-1 
insertions in the majority of temporal and spatial contexts. Some of these mechanisms 
involve interference with the transcription of LINE-1, and other mechanisms occur at a 
later stage, regulating LINE-1 at the RNA or protein level (Bodak et al., 2014).  
1.3 Structure of LINE-1 elements and their encoded proteins 
Transposition-competent LINE-1 elements are roughly 6-7 kb in length (Scott et al., 1987), 
containing a 5’UTR with an internal promoter (Minakami et al., 1992), two open reading 
frames (ORFs), and a 3’UTR containing a poly (A) tail (Dombroski et al., 1991). The 
LINE-1 ORFs encode two proteins: ORF1p and ORF2p (Scott et al., 1987). These proteins 
are required for efficient mobilization of LINE-1 elements (Moran et al., 1996). Despite 
their similar names, the encoded proteins are quite different from one another. 
ORF1p is an approximately 40kDa protein possessing RNA binding and chaperoning 
activity (Kolosha and Martin, 2003; Martin and Bushman, 2001). The protein binding of 
LINE-1 RNA to ORF1p is a necessary step of retrotransposition (Kulpa and Moran, 2005). 
ORF2p is a larger protein (150kDa) that possesses both endonucleases (Feng et al., 1996) 
and reverse transcriptase activities (Martin, 2010; Mathias et al., 1991). The activities of 
both proteins are required for LINE-1 mobility. 
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1.4 LINE-1 retrotransposition: how does it work? 
Active LINE-1 retrotransposition requires the transcription of a full-length RNA molecule 
from the 5’ internal promoter, which is translated into the proteins ORF1p and ORF2p in 
the cytoplasm (Alisch et al., 2006; Moran et al., 1996). The LINE-1 mRNA is then capable 
of binding the translated proteins, forming a ribonucleoprotein (RNP) complex with their 
respective proteins. This RNP is then imported into the nucleus, where it initiates reverse 
transcription at the target site with a process called target-primed reverse transcription 
(TPRT) (Luan et al., 1993). As previously eluded to, most LINE-1 elements present in the 
mammalian genome are immobilized. This is because of poor processivity during the 
reverse transcription step or potentially because of post-transcriptional and post-
translational LINE-1 RNA degradation. 
 
1.5. LINE-1 Promoter 
Although the mouse and humans LINE-1s share similar ORFs, they differ markedly within 
the 5′ UTR sequence. This difference is believed to be responsible for the differences in 
transcriptional activities in these two species (Severynse et al., 1992). Particularly, the 5′-
UTRs of the full-length human LINE-1s carry two types of internal promoters, namely 
sense and antisense (Hancks & Kazazian, 2012). In contrast, 5′-UTRs of the full-length 
mouse LINE-1s contains a sequence of 200 bp. These tandemly repeated sequences are 
known as monomers (Severynse et al., 1992). The number of the monomer repeats may 
vary among the individual mouse LINE-1 families, where the copy number is linked with 




   
Moreover, the monomers are used to subclassify LINE1 into different subfamilies, and 
their presence or absence generally determine which transcription factors (TFs) would 
regulate the transcription of these elements. For instance, the promoter of the murine Tf 
subfamily binds to the YY1 (YY1 Transcription Factor) factor, whereas the TA subfamily 
does not conserve this region (Severynse et al.,1992). That again suggests that the promoter 
activity pattern may vary in between the subfamilies and species. 
1.5.1 Sense promoter 
The first 100 base pairs of the 5′- UTR carries an internal sense promoter. This is essential 
for transcription initiation (Swergold 1990).  However, this region shows high variability. 
In other words, this is very poorly preserved regions in mammals (Zimmerman, 1997; 
Eppig et al., 2012). Additionally, this exhibits a frequent stop codons and a high GC content 
(˃50%) in comparison to the rest of the LINE1 sequence (Aporntewan & Mutirangura, 
2011, Eppig et al., 2012). These features suggest that this region’s function could be 
controlling the LINE1 transcription (Aporntewan & Mutirangura, 2011; Eppig et al., 
2012). 
1.5.2 Antisense promoter  
Besides the transcription of the forward LINE-1 RNA, LINE-1 elements also have 
antisense promoters that can drive the expression of nearby genes. The antisense promoter 
is found in the 5’UTR (Speek, 2001) of a LINE-1 element. The transcribed mRNA 
transcripts (initially discovered in 2001) were chimeric, containing a 5’UTR from LINE-
1, and exons from the nearby genes. Subsequently, almost 1000 antisense transcripts were 
identified in a comprehensive computational study (Criscione et al., 2016). Some of these 
chimeric transcripts were also found to be unique to (or, up-regulated in) cancer cell lines 
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(Cruickshanks and Tufarelli, 2009; Weber et al., 2010). More recent studies have 
implicated LINE-1 antisense promoter in regulating the tissue-specific expression of long 
non-coding RNAs (Chishima et al., 2018). A large number of these chimeric transcripts 
present in the mammalian genome could reflect a global mechanism for regulating lineage-
specific transcription programs. This is consistent with other studies suggesting LINE-1 
elements can have regulatory functions in the mammalian genome (Elbarbary et al., 2016).  
1.6 Regulation of LINE-1 expression 
The expression of LINE-1 elements in mammals is tightly controlled, protecting their 
genomes from deleterious effects of random integrations. Initial work suggested that the 
transcription of LINE-1 was restricted to the pluripotent cells of the primordial germline 
and in embryonic development (Garcia-Perez et al., 2007; Martin and Branciforte, 1993; 
Ostertag et al., 2002; Packer et al., 1993; Trelogan and Martin, 1995) where a global wave 
of epigenetic remodelling that occurs during embryogenesis allows them to become 
upregulated. However, more recent evidence discussed above suggests that their regulation 
is complex, multifaceted and that they can be expressed in somatic cells. 
1.6.1 LINE-1 and chromatin landscape 
An important layer that governs the regulation of mammalian gene expression is 
epigenetics and chromatin structure. Epigenetics refers to covalent modifications to the 
DNA and the associated proteins (chromatin) that do not modify the actual DNA sequence. 
Despite the lack of changes to the underlying DNA sequence or transcription factors, the 




   
LINE-1 elements are no exception to this rule: a powerful tool for regulation of LINE-1 
expression is through modulating the surrounding chromatin environment (Jachowicz and 
Torres-Padilla, 2016). One of the most studied mechanisms by which a repressive 
chromatin landscape can silence LINE-1 elements is through DNA methylation. 
1.6.2 DNA methylation 
DNA methylation is the direct modification to the DNA sequence, through the deposition 
of a methyl group at the 5’ carbon on the cytosine base (5mC). In the mammalian genome, 
this mark is primarily found at cytosine bases in the context of a CpG dinucleotide (Klose 
and Bird, 2006). DNA methylation is enzymatically catalyzed by a class of enzymes called 
DNA methyltransferases. These enzymes either act upon an unmethylated DNA strand, 
depositing de novo DNA methylation or act upon a hemimethylated transcript to maintain 
DNA methylation patterns after DNA replication. DNMT3A and 3B are the de novo 
methyltransferases, DNMT1 is the maintenance methyltransferase that faithfully 
recapitulates DNA methylation following semi-conservative replication (Edwards et al., 
2017).  
DNA methylation is broadly associated with the repression of transcription; however, its 
precise relationship with gene activity is more complex than initially recognized. One 
genomic context in which its repressive role is less controversial is in the silencing of 
transposable elements (Arand et al., 2012; Jones and Takai, 2001; Walsh et al., 1998). 
DNA is typically hypermethylated at the promoters of LINE-1 elements in mammalian 
cells (Meissner et al., 2008). This DNA methylation is thought to have important functional 
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consequences because in mouse embryonic stem cells lacking any active DNA 
methyltransferase enzymes, the transcription of LINE-1 is elevated (Tsumura et al., 2006).  
1.6.2.1 DNA methylation in development 
The role of DNA methylation in silencing LINE-1 elements is certainly significant in 
somatic tissues (Arand et al., 2012). The findings of various studies have indicated that 
DNA methylation has a complex relationship with LINE-1 activity, with cell-type-specific 
regulatory mechanisms. Further complicating this, it is the evidence that the regulation of 
LINE-1 elements by DNA methylation could be locus-specific (Philippe et al., 2016; 
Vafadar-Isfahani et al., 2017). Historically, studying individual LINE-1 elements has been 
technically challenging, but it has recently been shown that in some cases, DNA 
methylation at LINE-1 promoters does not correlate with their expression (Vafadar-
Isfahani et al., 2017). The locus-specific activity of LINE-1 elements was also analyzed in 
cancer cells in a report published in 2016.  Researchers observed that the majority of 
transpositionally active LINE-1 elements (the youngest and human-specific LINE-1 
subfamily, LINE-1HS-Ta) were transcribed from a few cell-type-specific loci (Philippe et 
al., 2016). The researchers found that in their cancer cell lines where they detected LINE-
1HS-Ta, the general mechanisms regulating LINE-1 activity were not perturbed. This 
suggests that locus-specific and cell-type-specific regulatory mechanisms for LINE-1 
repression exist in distinct cellular contexts, and that heterogeneity can exist in an already 





   
1.6.3 Histone modifications  
Another mechanism of epigenetic regulation of transcription is through the post-
translational modification of histone tails, a powerful regulator of chromatin structure and 
gene expression (Bannister and Kouzarides, 2011). Histone tails can be modified at several 
amino acid residues by the addition of small chemical groups, with the most common being 
methylation, acetylation and phosphorylation. The resulting landscape of histone 
modifications regulates the structure and function of chromatin, fine-tuning gene 
expression profiles in a different cell type- and locus-specific contexts. The trimethylation 
of lysine 9 on histone H3 (H3K9me3) is most commonly associated with the silencing of 
repetitive sequences and transposable elements (Karimi et al., 2011). 
Interestingly, H3K9me3-mediated LINE-1 silencing was found to be restricted to mouse 
embryonic stem cells. In lineage-committed cell types, DNA methylation was observed at 
the H3K9me3-repressed LINE-1 loci, suggesting a shift from histone methylation-
dependent silencing to DNA methylation-mediated silencing (Walter et al., 2016). 
A very recent and comprehensive study aimed to explore the interplay of various chromatin 
marks at transposable elements in mouse embryonic stem cells (He et al., 2019). To analyze 
the effects of histone modifications on LINE-1 expression, various histone-modifying 
enzymes were knocked down and changes in chromosome accessibility and transposable 
element expression were assessed. The results revealed that a complex landscape of histone 
modifications exists at LINE-1 elements. While the authors acknowledge that definitively 
mapping chromatin marks at LINE-1 sequences is difficult owing to their abundance and 
sequence identity, they find various histone marks enriched at LINE-1 elements including 
H4R3me2, H3K4me1, H3K27ac, H3k9me3 and others (He et al., 2019). These histone 
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marks were overlapping and associated with changes to chromatin accessibility. This can 
be assayed by a technique called as Assay for Transposase-Accessible Chromatin followed 
by sequencing (ATAC-seq), and gene expression programs. This study highlights the 
complexity of the epigenetic regulation of these elements and suggests that much of the 
role of epigenetic systems in the cell is to manage the expression of mobile DNA.  
Besides the transcriptional regulation of LINE-1 with the epigenetic regulation, several 
posttranscriptional, translational, and even posttranslational regulations of LINE-1 
elements are also involved to restrict LINE-1 mobilization in the mammalian genome. 
1.7 LINE-1 activity in the development 
LINE-1 expression during development has been a particularly important area of research. 
The dynamic remodeling of the transcriptional and epigenomic landscapes during the 
transition from pluripotency to the acquisition of lineage commitment affords LINE-1 
elements an opportunity for upregulation and activity. 
Initial understanding of LINE-1 activity led to the belief that LINE-1 elements were only 
expressed in vivo in the early stages of mammalian embryogenesis, or during the 
specification of primordial germ cells (precursors of the gametes). Later, retrotransposition 
assays showed LINE-1 expression and retrotransposition can occur in a variety of somatic 
cell types, and also in vitro culture models, including neural progenitor cells, cancer cell 
lines and other mammalian cell culture contexts (Muotri, 2016). LINE-1 expression and 
mobilization have been studied extensively both in vivo using mouse models and tissue 




   
1.7.1 Evidence of LINE-1 expression in vivo during development 
The historical view of LINE-1 retrotransposition is that LINE-1 elements are only active 
during embryogenesis and malignant transformation. This was challenged by the finding 
that LINE-1 retrotransposition can occur in various cells of the brain, and LINE-1 mRNA 
and proteins have been detected in various adult somatic tissues (Belancio et al., 2010; 
Richardson et al., 2014). The activity of LINE-1 in somatic tissues and disease contexts 
will be discussed in detail in later sections. 
LINE-1 activity during development in vivo must be tightly regulated to prevent genomic 
instability and the accumulation of mutations. This is particularly important during 
development, where the genome undergoes rapid and dynamic remodeling, associated with 
more permissive chromatin states (Seisenberger et al., 2013). These permissive states are 
associated with genomic activation, and LINE-1 expression must be kept in check to ensure 
the cell retains control of its activity. The control of LINE-1 is particularly important in 
germ cells, where any new LINE-1 insertions will be passed on to the next generation. 
LINE-1 expression must be controlled in the pre-implantation embryo, which represents 
another crucial period of epigenomic remodeling.  
Endogenous LINE-1 elements are expressed at various points in the mouse embryo 
(Jachowicz et al., 2017; Packer et al., 1993; Veselovska et al., 2015; Watanabe et al., 
2008). LINE-1 expression has also been shown to be abundant in the two-cell stage 
(Fadloun et al., 2013), and decrease over embryonic time between the 2 and 8 cell stage. 
The presence of these transcripts has been shown by Northern blot (Packer et al., 1993), 
RNA Fluorescence in Situ Hybridization (FISH), and reverse transcriptase-polymerase 
chain reaction (RT-PCR) (Fadloun et al., 2013).  
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LINE-1 mRNA and protein are expressed in the germline in human and mouse cells 
(Peaston et al., 2004; Trelogan and Martin, 1995). However, to prevent their over-
activation and the disruption of genome integrity by these elements, they are tightly 
controlled by various means. In the germline, specific proteins exist to post-
transcriptionally regulate LINE- activity. These proteins (termed PIWI proteins) are 
discussed in detail in a later section. Without the regulatory effects of these proteins, LINE-
1 transcripts accumulate in the testes of adult male mice, but not in wild type mice. This 
was shown using in situ hybridization as well as RT-PCR detecting mRNA transcripts 
(Aravin et al., 2007; Carmell et al., 2007). 
1.8 LINE-1 in the embryo, somatic tissues, and disease contexts 
1.8.1 Expression of LINE-1 in the embryo  
Endogenous LINE-1 elements are highly expressed in the mouse embryo (Jachowicz et al., 
2017). LINE-1 elements are transcribed soon after fertilization (Fadloun et al., 2013). 
Transcription is highest at the two-cell stage and is rapidly reduced after the blastocyst 
stage of development. Interestingly, this is (at least initially) primarily attributable to a loss 
of activating marks, rather than a gain of repressive marks (Fadloun et al., 2013). LINE-1 
expression is higher in the in vivo embryo than in cultured mouse embryonic stem cells 
(Jachowicz et al., 2017). This could potentially be explained by the increase in DNA 
methylation in cultured cells relative to the cells of the inner cell mass (Ficz et al., 2013).   
Importantly, activation of LINE-1 elements during development does not appear to merely 
be a consequence of spurious activation because of epigenome remodeling. It has been 
shown that inhibiting LINE-1 expression before the two-cell stage interferes with the 
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development of the embryo, reducing developmental progression (Jachowicz et al., 2017). 
LINE-1 elements have been implicated in modulating the wide-spread changes in 
chromatin organization observed during early mouse development (Jachowicz et al., 
2017). This suggests that LINE-1 expression has genuine roles in normal mammalian 
biology and the mRNAs are not simply problematic transcripts that are only activated when 
silencing mechanisms are perturbed. Recently, Percharde et al. revealed that in mouse 
embryonic stem cells (ESCs) and also in pre-implantation embryos, LINE1s have a critical 
role in directing the self-renewal capability, transcriptional regulations and also overall 
developmental potency (Percharde et al., 2018). 
1.8.2 Germ cell expression of LINE-1  
An important finding in the past let us believe that mutagenesis mediated by transposable 
elements may occur in the germline of humans. In that event, CYBB gene was inserted by 
LINE-1 most likely during meiosis I of maternal primary oocyte genome of a male patient 
with a chronic granulomatous disease (Boruha et al., 2002). From then onwards, it is well 
established now that transpositional events in the germline might be a major source of 
genomic variations and diseases in the human population. In that case, the most active 
transposable elements: Alus, LINE-1s and SVAs are carrying out the events of reshaping 
the genomic landscape of haploid cells and at the same time causing different rare genetic 
diseases. It is noteworthy here that these reshaping events not only include insertional 
events but also include the deletions of the host DNA sequence (Gilbert et al., 2002). 
The exact timing of the endogenous de novo retrotransposition in human germline 
remained unclear. A recent study with mouse model indicates that heritable de novo 
insertions might start to take place as early as prior germline specification in mammals. In 
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that study, a new LINE-1 insertion was found in 3-5% of offspring, whose both parents 
had no such insertion in somatic cells, but the male parent had <1 copy insertion per cell 
in both testicles (Richardson et al., 2017). That result indicated that new LINE-1 insertion 
in germline-restricted mosaic male parent took place, most likely, in early primordial germ 
cells (PGCs) before they colonize genital ridges to form testicles anytime during E10.5-
E12.5 (Ewen et al., 2010). Due to ethical considerations, the option of proving this notion 
of human PGC development is limited. 
1.8.3 LINE-1 in somatic cells 
Initially, human somatic LINE-1 retrotransposition events were thought to be relatively 
rare. However, more recent studies have shown that LINE-1 expression and mobilization 
occurs in a variety of somatic cells, for example in tumors (Burns, 2017), and interestingly, 
in various tissues of the brain (Goodier, 2014; Suarez et al., 2018). 
1.8.4 LINE-1 in the brain  
Among the somatic organ systems, the brain has emerged as one of the most active sites 
for retrotransposition during development. It is thought that a certain level of 
retrotransposition might be advantageous for neuronal development by promoting genomic 
diversity. On the other hand, excessive expression or retrotransposition could have 
deleterious effects on neural functions. 
Retrotransposition in the mammalian brain was first demonstrated in the laboratory mouse. 
In 2005, the Gage lab identified new retrotransposition events in many regions of the mouse 
brain (Muotri et al., 2005). The insertions were initiated from a human LINE-1-based 
transgene and seemed to occur only in neurons but not in oligodendrocytes and astrocytes 
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during embryonic and adult neurogenesis. LINE-1 ORF1p was also detected in several 
regions of the brain, including the ventricular zone and the dentate gyrus of the 
hippocampus. In 2009, the same group showed variable but significant levels of increase 
in endogenous LINE-1 copies in multiple regions of human brain samples (Coufal et al., 
2009). Subsequently, two separate groups were able to confirm somatic LINE-1 insertions 
in the human brain at the sequence level (Baillie et al., 2011; Evrony et al., 2012). Together 
these studies established the brain as a hub for active retrotransposition in humans and 
heralded a new era of investigating the extent of somatic mosaicism in the brain and its 
functional implications.  
How frequently does LINE-1 retrotransposition occur in a human brain? The answer to this 
question is complicated by both the methodology used and the inherent variation in 
retrotransposition. Using quantitative PCR on bulk samples the initial report suggested an 
increase of 80 copies of LINE-1 per cell in the hippocampus (Coufal et al., 2009). The 
figure was later refined by two studies employing advanced single-neuron sequencing 
analyses. The Walsh lab estimated up to 1.1 somatic LINE-1 insertions per cortex and 
caudate neurons (Evrony et al., 2012). The Faulkner lab’s estimation was an average of 
13.7 new insertions per hippocampus neuron (Upton et al., 2015). The discrepancy 
between these two studies likely originated from technical variations in sequencing 
approaches, data analytics and validation methods (Evrony et al., 2016). Indeed, factoring 
the most stringent validation criteria into the calculation, the frequency of unique LINE-1 
insertions may be as low as 0.04 or 1 in every 25 neurons (Evrony et al., 2012). The 
variation in estimated retrotransposition frequencies does not necessarily diminish the 
potential functional impact of such insertions. If we assume 0.04 insertions per neuron as 
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the tangible minimum, there will still be approximately 3.4 billion unique somatic 
insertions among 86 billion neurons in a typical adult human brain! Also, somatic 
retrotransposition is variable in different individuals as well as in different regions of the 
brain.  
Information about the developmental timing of LINE-1 retrotransposition in the brain 
remains scarce. Nevertheless, important insights have been gained from lineage tracing 
analysis of two somatic LINE-1 insertions in a normal human brain (Evrony et al., 2015). 
One insertion was distributed over the entire left hemisphere and present not only in 
neurons but also in non-neuronal cells, suggesting that it arose in one of the earliest 
progenitor cells of the central nervous system. In contrast, the second insertion was 
restricted to neurons at the left middle frontal gyrus, suggesting that it occurred relatively 
late during cortical development in the embryo. Unlike the original mouse study, single-
cell analyses have also identified somatic LINE-1 insertions in glial cells (Evrony et al., 
2015; Upton et al., 2015; Erwin et al., 2016). Whether differentiated glial cells support de 
novo retrotransposition is unknown as many such insertions could have originated in 
progenitors common to neurons and glia (Evrony et al., 2015; Upton et al., 2015). Although 
it has not been established in vivo, in vitro cell culture experiments have provided a 
comparison of neural stems cells, neuronal progenitor cells (NPCs) and terminally 
differentiated neurons in their capabilities of supporting retrotransposition. The 
overwhelming evidence pinpointed neuronal progenitor cells as the hub for LINE-1 
insertional events. Besides, both human and rodent LINE-1 promoters possess overlapping 
SOX2/WNT binding sites. In these cells, Sox2 is downregulated as Wnt is upregulated. The 
latter activates LINE-1 promoter activity and transcription (Kuwabara et al., 2009).  
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Whether LINE-1 retrotransposition plays a functional role in normal brain physiology is 
not yet understood. Given the connectivity of brain cells and the estimated collective 
mutational burden in the entire brain, somatic retrotransposition has the potential to exert 
a significant impact on neuronal functions. Of relevance, in both rat NPCs and human 
hippocampal neurons, somatic LINE-1 insertions can occur in neuronally expressed genes, 
including those that are involved in different synaptic processes (Muotri et al., 2005; Upton 
et al., 2015). Notably, besides insertional mutagenesis, LINE-1s can also remodel the 
genomic landscape of neurons by inducing large genomic DNA deletions, a process that is 
retrotransposition independent (Erwin et al., 2016). In this context, genomic diversity may 
beget a functional diversity within the human brain. 
On the other hand, excessive LINE-1 mobilization in the brain has been linked to many 
neurodevelopmental and neurodegenerative disorders. For example, the rate of LINE-1 
retrotransposition was found to be higher in NPCs derived from human tissue of a patient 
with Rett syndrome (RTT), a neurodevelopmental disorder due to a mutation in the X-
linked MECP2 gene (Muotri et al., 2010). 
1.8.5 LINE-1 in other somatic tissues 
LINE-1 mRNA has been detected, although mostly at low levels, in a variety of cell types. 
Interestingly, a human retrotransposition assay in mouse models suggests there is no 
inherent barrier to LINE-1 protein expression and activity in somatic cells (Ostertag et al., 
2002). A comprehensive study from 2010 studied an array of tissues, finding LINE-1 RNA, 
protein, and de novo insertions in most human (somatic) tissues (Belancio et al., 2010). 
Whilst specific reports of LINE-1 expression and activity in healthy somatic tissues are 
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rare, expression and activity have been noted in cells of the gastrointestinal system as well 
as in the esophagus.  
In a study investigating Barrets Esophagus and esophageal cancer found that although 
LINE-1 retrotransposition events were seldom found in normal tissue, LINE-1 protein 
expression was detected in all tissues examined (Doucet-O'Hare et al., 2015). LINE-1 
protein expression has also been found in cells closely associated with male germ cells, 
such as Sertoli cells and vascular endothelial cells, likely linked to transposition in the 
gametes (Ergun et al., 2004).   
These reports suggest that whilst the expression of LINE-1 occurs outside of the germline 
and neuronal tissues, the level of activity is highly heterogeneous between tissues. Active 
retrotransposition is likely inhibited by other means in these cells to prevent the 
accumulation of DNA damage.  
1.8.6 LINE-1 in disease states 
LINE-1 is associated with various disease states (Hancks and Kazazian, 2016). This 
includes in the initiation and progression of cancers, autoimmune disorders and Mendelian 
diseases.  
In the germline, LINE-1 can act as a mutagenic agent through insertional mutagenesis – 
disrupting exons and inducing double-stranded breaks (Belancio et al., 2008). This has 
been shown as the causative mutation in cases of haemophilia A (Kazazian et al., 1988), 
choroideremia (Van den Hurk et al., 2007), β thalassemia (Lanikova et al., 2013) and 
various other diseases reviewed (Beck et al., 2011). Interestingly, a high number of these 
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disease-causing mutations are found on the X chromosome, potentially implicating 
recombination in LINE-1 insertions (Belancio et al., 2008).  
LINE-1 insertions can also occur in somatic cells, although these effects are not inherited 
by the next generation. LINE-1 over-expression and mobilization has also been associated 
with multiple neuropathologies (Bundo et al., 2014; Liu et al., 2016; Suarez et al., 2018; 
Tan et al., 2018) and is linked with genomic instability and malignancy in cancers (Burns, 
2017).  
1.8.7 LINE-1 expression in cancer 
LINE-1 protein expression is a hallmark of malignancy (Rodic et al., 2014). LINE-1 hypo-
methylation, activation and integration is associated with many cancers, often correlated 
with poor prognosis. LINE-1 integration can be a source of genome instability through 
inducing DNA damage, insertional mutagenesis and chromosomal rearrangement. The 
dysregulation of LINE-1 elements, often by hypomethylation, can contribute to the 
pathogenicity of tumors (Briggs et al., 2018; Burns, 2017; Carreira et al., 2014; Schulz, 
2006; Doucet-O'Hare et al., 2015; Miki et al., 1992; Kerachian and Kerachian, 2019; Rodic 
et al., 2014). Certain tumor types are more prone to LINE-1 retrotransposition (Table 1.1). 
For example, tumors of the gastrointestinal tract (Lee et al., 2012; Solyom et al., 2012), as 
well as hepatocellular carcinomas, prostate and ovary cancers. These retrotransposition 
events usually correlate with LINE-1 mRNA and protein expression, suggesting that 
mechanisms to diminish LINE-1 expression have been compromised (Burns, 2017; Rodic 
et al., 2014). The activity of LINE-1 in cancer pathogenesis is heterogeneous; sometimes 
LINE-1 expression and insertions are early events in tumorigenesis  (Scott et al., 2016; 
20 
 
   
Tubio et al., 2014), in other cases, they accumulate in downstream events, likely as an 
effect of better conditions for LINE-1 expression to occur (Burns, 2017).  
 
Table 1.1: Classification of cancers in human based on somatic retrotransposition 
activity (adopted from Saha & An, 2019). 
 
1.9. Tools for studying mammalian LINE-1 retrotransposition 
Studying mobile elements has been historically challenging. This is due to their abundance 
in the genome, repetitive sequences, and the accumulation of polymorphisms. However, 
the development of cleverly designed reporter systems as well as an adaptation of classic 
molecular biology techniques and advances in sequencing technology have produced a 
range of tools for use in studying LINE-1 biology. Some of these tools and methods are 
discussed below. 
1.9.1 LINE-1 retrotransposition reporter constructs  
The first published cultured cell LINE-1 retrotransposition assay in 1996 represented a 
significant advance in the field, as it allowed retrotransposition to be studied in real-time 
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(Kopera et al., 2016; Moran et al., 1996). The rationale behind this assay is the integration 
of a reporter construct that is only detectable when a LINE-1 element is transcribed, reverse 
transcribed, and integrated elsewhere in the genome. A retrotransposition indicator cassette 
is integrated into 3′-UTR of LINE-1, in the opposite direction of LINE-1 transcription. This 
cassette consists of a reporter gene sequence, which is interrupted by an intron which is 
transcribed in the same direction as the LINE-1 mRNA. The reporter construct can only be 
expressed when transcription occurs from the LINE-1 promoter, which splices out the 
intron from the reporter cassette, resulting in reverse transcription of  LINE-1 RNA and 
the integration of new copies of the LINE-1 sequence as well as the reporter cassette into 
the genome. The cells possessing a successful integration can be selected based on the 
presence of the reporter construct, and researchers now have a set of tools to analyze LINE-
1 activity (Kopera et al., 2016; Moran et al., 1996). 
Several adaptations of this assay have permitted various studies on LINE-1 activity in a 
range of systems (Rangwala and Kazazian, 2009). This includes studies of LINE-1 
retrotransposition in the neural progenitor cells (Coufal et al., 2011; Coufal et al., 2009), 
non-dividing primary human cells (Kubo et al., 2006) and the generation of a mouse model 
(Ostertag et al., 2002). Important regulatory questions have also been investigated using 
derived assays, including the epigenetic silencing of the LINE-1 retrotransposition (Garcia-
Perez et al., 2010), and the cellular kinetics of retrotransposition (Ostertag et al., 2000). 
However, concerns are there regarding the robustness of these tools which may bring about 





   
1.9.2 Studies in cultured cells  
Embryonic stem cells are a frequently used model for studying the regulation of molecular 
events and the role of different regulatory factors. This is a result of the plastic genome of 
pluripotent cells and the ability of these cells to transition into a variety of different cell 
types in culture. Embryonic stem cells are of particular interest in the field of LINE-1 
biology, as LINE-1 transcripts, as well as active LINE-1 transposition, are frequently 
detected in these cells (Garcia-Perez et al., 2007). 
Using induced pluripotent stem cells (iPSCs) from human neonatal dermal fibroblasts, it 
has also been shown that LINE-1 expression is elevated during reprogramming from the 
somatic cell to the induced pluripotent state. This activity resulted in low-level insertions 
of LINE-1 elements (Arokium et al., 2014). This study could be of importance to the iPSC 
field, as it cautioned researchers about potential genotoxic effects that occur during somatic 
cell reprogramming. 
1.9.3 Mouse models 
To better understand human LINE-1 retrotransposition, Ostertag and colleagues generated 
a transgenic mouse model, in which eGFP is conditionally expressed in the spermatocytes 
through a spermatozoa-specific preproacrosin promoter (Ostertag et al., 2002). A 
functional eGFP is only produced when a retrotransposition event has occurred (Moran et 
al., 1996). This is because the eGFP cassette contained an antisense γ-globin intron that 
cannot be spliced out. However, when the cassette is cloned into the LINE-1 3’UTR, in an 
antisense orientation, retrotransposition can remove the antisense intron and produce a 
functional eGFP (Moran et al., 1996; Ostertag et al., 2002; Ostertag et al., 2000). Using 
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this system, researchers discovered that one de novo insertion was occurring in every 70 
sperm for mice in the germ cells of mice. Although, later An et al found that the mutagenic 
effect of LINE-1 insertions was relatively high as 1 insertion per 3 sperms using CAG-
ORFeus transgenic mouse line (An et al., 2006). Mouse models have also been utilized to 
show that integration events occur more often in embryogenesis than in the germ cells, 
generating somatic mosaicism (Kano et al., 2009). 
1.9.4 High throughput sequencing 
Technical challenges are put forward by the sequence abundance of LINE-1 and their 
polymorphism in the genome for their detection. To circumvent these issues, more 
advanced methods of high throughput sequencing have been implemented to study the 
expression, regulation and activity of LINE-1 elements in the genome (Xing et al., 2013). 
For example, Retrotransposition Capture Sequencing (RC-seq) (Baillie et al., 2011; 
Sanchez-Luque et al., 2016), which is a method that enriches sequencing libraries for 
retrotransposon insertions. RC-seq achieves this using biotinylated capture probes, which 
target the 5’ and the 3’ end of the LINE-1 consensus sequence. This reduces the level of 
PCR amplification required and limits biases associated with normal genome-wide 
sequencing of rare genomic elements, such as heterogeneous retrotransposition events. 
1.9.5 In vitro biochemical assays 
In vitro biochemical assays have also been valuable in providing insights into LINE-1 
function (Viollet et al., 2016). These have been focused on detecting the retrotransposition 
activity of ORF2p.  
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The LINE-1 Element amplification Protocol (LEAP) enables researchers to assess the 
ability of ORF2p to reverse transcribe LINE-1 mRNA in vitro using the purified LINE-1 
RNP from human cells harboring LINE-1 expression constructs (Kopera et al., 2016; 
Kulpa and Moran, 2006; Viollet et al., 2016). The assay involves the transfection of cells 
with constructs expressing differentially tagged ORF1p and ORF2p. The RNP complexes 
are purified from cells by centrifugation or immunoprecipitation. The RNP is then 
incubated with an oligonucleotide (termed as LEAP adapter) to prime cDNA synthesis. 
The LINE-1 cDNAs are the PCR-amplified primers complementary to the adapters and the 
LINE-1 construct. The PCR products can then be visualized and characterized (Kopera et 
al., 2016). This assay has been used to investigate the process of target-primed reverse 
transcription. The direct LINE-1 extension assay (DLEA) is a similar assay with an 
alternative design to detect reverse transcription of LINE-1 mRNAs. DLEA involves the 
incorporation of a radiolabeled nucleotide before primer elongation (Monot et al., 2013; 
Viollet et al., 2016). 
ORF1p, is one of the proteins essential for retrotransposition, is expressed in large extents 
in the cellular cytoplasm. These proteins can also be targeted with monoclonal antibodies 
as a robust indicator of LINE-1 expression in cells or tissues (Sharma et al., 2016).  
1.10 Detection of LINE-1 expression 
Studies of retrotransposons have been largely hindered by their repetitive and abundant 
nature. This makes amplification, detection and sequencing of these regions challenging.  
1.10.1 Protein-based detection: One way to study LINE-1 activity in terms of its 
expression and localization is through classical detection methods, such as immuno-based 
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assays. This typically involves using an antibody against ORFP2. Whilst this is a robust 
method, it will not detect LINE-1 elements that are transcribed into RNA but not translated 
into proteins. Therefore, it does not take into account the post-transcriptional regulation of 
LINE-1 transcripts. (Sharma et al., 2016). However, it is a useful method for detecting 
protein levels as well as localization at a single nucleus level.  
1.10.2 Nucleic acid-based detection: First, RNA-FISH is a technology that is useful for 
detecting LINE-1 expression, as it also benefits from single nucleus resolution (Jachowicz 
et al., 2017). However, the advantage of RNA-FISH over immune-detection methods is 
that nascent transcripts are assayed, meaning transcription is more directly measured. On 
the other hand, LINE-1 insertion events have also been tracked with DNA FISH, detecting 
retrotransposition patterns using a LINE-1/neomycin vector, which is only detectable using 
FISH probes when the Neomycin gene has been reverse transcribed as a result of LINE-1 
activity (Bojang and Ramos, 2016). Microscopy can also be implemented finally to both 
of these approaches to analyze the LINE-1 expression. 
Northern blot analysis remains the most traditionally used and reliable technique to detect 
LINE-1 transcription which uses probes complementary to LINE-1 RNA (Deininger and 
Belancio, 2016). The probes can be designed to detect particular sub-types of LINE-1 
elements, such as full-length LINE-1 elements or the discrimination between sense and 
antisense transcripts (Deininger and Belancio, 2016).  
1.11 Concluding remarks 
While initially transposable elements were thought merely to be marks of parasitic 
infection, it is becoming increasingly clear that they play fundamental roles in mammalian 
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biology. LINE-1 elements, in particular, are a crucial part of the mammalian genome. 
Understanding the tight control of their expression patterns as well as their function in 
normal and diseased cells is a question of utmost importance in the fields of epigenetics, 
transposon biology and developmental biology.  
The huge abundance of LINE-1 elements in the human and mouse genomes, repetitive 
nature and complex expression patterns requires the development of innovative 
technologies and the careful design of experimental procedures used to study these 
elements. With the advancement of these tools, we have learned of the multi-layered 
regulation of these elements at all layers of their expression and mobility, and we have 
discovered novel functions of transposable elements.  Aside from their clear roles in 
shaping the landscape of the mammalian genome, it appears that cells have evolved ways 
to utilize LINE-1 expression and retrotransposition.  
The mechanism and purpose of fine-tuned LINE-1 expression during embryogenesis has 
been a frequently asked question. Recently, researchers have made progress in answering 
such questions; LINE-1 elements appear not to be an unfortunate side-effect of epigenetic 
remodeling but are required for the normal development of the embryo (Jachowicz et al., 
2017). The implication of LINE-1 elements in such crucial processes along with the 
emerging theme of their context- and locus-dependent expression (He et al., 2019) patterns 
are likely to have a huge impact on the future of the field.  
1.12 Objective of the current project 
Retrotransposons belong to a class of mobile genetic elements that comprise 43% of the 
human genome (Lander et al., 2001). Long interspersed elements type 1 (LINE-1s) are the 
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most abundant retrotransposon, accounting for 17% of the human genome. The human 
genome is impacted by retrotransposons in multiple ways (Goodier and Kazazian, 2008). 
Insertional mutagenesis is the most noticeable form of alteration and has been observed in 
more than 100 cases of human diseases, including cancer and birth defects (Hancks and 
Kazazian, 2016). The majority of LINE-1s became immobile during the course of 
evolution. Although LINE-1s more retrotranspose in the germline cycle, some 
retrotransposons may also be active in somatic tissues (Belancio et al. 2010; Ergun et al. 
2004). It is estimated that among the total number of 500,000 LINE-1s presents in the 
human genome, 80-100 LINE-1s remain competent for retrotransposition (Brouha et al., 
2003). LINE-1 insertions can also impact the genome by altering gene expression. A full-
length LINE-1 is typically 6-7 kb and has its promoter located in the 5′ untranslated region 
(UTR) (Swergold, 1990). Retrotransposition is only possible when LINE-1 is expressed, 
and because LINE-1 transcription is regulated by its 5’UTR promoter, it is essential to 
understand the spatiotemporal control of LINE-1 promoter activity. Besides the small set 
of retrotransposition-competent LINE-1s, an additional set of 7000 immobile LINE-1s still 
carry active promoters, which are capable of producing transcripts (Khan et al., 2006). The 
vast number of intact LINE-1 promoters when active may control the expression of protein-
coding genes and also can produce chimeric transcripts that might lead to pathogenic 
conditions, like cancer. It has also been proposed that activated LINE-1 promoters may 
trigger initiation of cancer through epigenetic changes (Wilkins, 2010). Nevertheless, till 
today no attempt has been made to profile LINE-1 promoter activities in a locus dependent 
manner in vivo. Therefore, this project will employ transgenic mouse model to profile 
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locus-dependent LINE-1 promoter activities in various somatic tissues as well as in gonads 
throughout different developmental time points. 
It is extremely technically challenging to monitor transcriptional activities of individual 
endogenous LINE-1s due to high sequence homology. Toward this goal, we generated 
single-copy 5’UTR-LacZ and 5’UTR-LacG mouse models. Both LacZ and LacG encode 
functional β-galactosidase, which can be visualized by X-gal staining. The LacG reporter 
gene lacks CpG dinucleotides, preventing transcriptional silencing via DNA methylation 
of the transgene body. After the mapping of the transgene locus in each line, different 
tissues from these single-copy transgenic mice were stained with X-gal to visualize LINE-
1 promoter activity in these tissues. In addition to that, we checked the influence of 
different orientations, sense and antisense, of the same endogenous promoter in a specific 
locus, Rosa26. Also, we attempted to identify the brain cells holding the transgene 
expression.  
We found that transgenic expression from two independent transgenic constructs varied 
significantly, with LacG lines having high expression compared to LacZ line. Besides 
interline, intraline variation was also observed in these two broad classifications. The 
kidney and thalamus of the brain were found to be a preferential hub of high promoter 
activity in most of the LacG lines. Also, an extreme contrast was observed between these 
two gene-targeted sense and antisense lines. 
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Chapter 2 




LINE-1s are tightly regulated with a different host-defense mechanism in a mammalian 
organ system. It is always intriguing how the LINE-1 promoters are regulated in a wide 
range of mammalian organs, how active they are through different phases of development, 
and what makes them mobilize smoothly or even repressed. It is extremely challenging to 
address these question with alive or post-mortem human samples. Therefore, to learn more 
about the regulation of the promoter activity, we generated two main transgenic mouse 
lines: LacZ and LacG, and also generated their sublines by mobilizing the transgene to 
different loci. In combination with an in situ histochemical detection technique (X-gal 
staining) aided by an automatic signal detection technique, we screened the main organs 
from the animals belonging to three different developmental time points. We found that 
LacZ sublines had very fewer signals in comparison to the LacG sublines. LacG071, a 
subline of LacG line, showed higher promoter activity in many organs than other sublines. 
A closer analysis of the expression pattern of the LacG sublines further elucidated a locus-
specific, organ-dependent, and age-linked regulation of LINE-1 promoter activity. 
Furthermore, kidney and thalamus were especially found to be as the most preferential 





   
2.2 Introduction  
Our understanding of LINE-1 regulation in our genome is limited from the organ- and 
locus-specific determinants. The extent of LINE-1 insertional polymorphism and the 
abundance of sequence identity in the mammalian genome put a challenge for studying 
these elements. Based on the recent evidence at both the RNA level (Philippe et al., 2016; 
Deininger et al., 2017) and reinsertion (Tubio et al., 2014), it is clear that only a few 
numbers of loci are retrotransposition competent. Therefore, it is high time to quantitate 
the locus-specific LINE-1 activity. Many studies adopted qPCR assay due to the ubiquity 
of the LINE-1 RNA. However, owing to the repetitive nature of LINE-1 sequences, it is 
hard to obtain an accurate, quantitative data based on LINE-1 transcripts. Furthermore, it 
is hard for qPCR assay to distinguish between a handful of the retrotransposition-
competent transcripts in a plethora of non-coding RNAs and truncated LINE-1 transcripts. 
This problem, however, can be addressed with implementing a transgenic approach. 
Until today, none of the approaches could quantify locus-dependent LINE-1 expression in 
situ in transgenic mouse models. Therefore, in this study, we examined the role of 
chromosomal location on the expression of endogenous LINE-1 promoter fused with 
reporter construct in a wide range of somatic as well as germline organs. To achieve that 
we generated single-copy transgenic mice by pronuclear injection, where transgenic 
constructs were mobilized into unique random chromosomal sites. The in vivo expression 
from some specific LINE-1 loci was assayed by histochemical staining for beta-





   
 




The study was carried out under the strict accordance with the guidelines provided by the 
National Institutes of Health in the Guide for the Care and Use of Laboratory Animals. The 
protocols were thoroughly approved by the Institutional Animal Care and Use Committees 
(IACUC). 
 
Plasmids Construction Details 
Plasmid pWA370 contains the 5’UTR-LacZ transgene. It is constructed via a three-way 
ligation of the BglII/NotI fragment from pMD002, the NotI/NcoI fragment from pWA125 
(Newkirk et al, 2017), and the NcoI/BamHI fragment from pQUEST-nucLacZ (a gift from 
Liqun Luo; Addgene plasmid # 24356; http://n2t.net/addgene:24356; RRID:Addgene 
24356) (Potter et al, 2010).  
Plasmid pWA371 contains the 5’UTR-LacG transgene. It is constructed via a three-way 
ligation of the BglII/NotI fragment from pMD002, the NotI/NcoI fragment from pWA125 
(Newkirk et al, 2017), and the NcoI/BglII fragment from pAAVf-EnhCB-lacZnls (a gift 
from Phillip Zamore; Addgene plasmid # 35642; RRID:Addgene 35642). 
Transfection 
The MW ratio between pWA370 (5930151.43 Da) and pWA371 (5324719.19 Da) is 1.1 
(pWA370/pWA371). To be fair for expression comparison, we adjusted the plasmids 
amount to achieve an equal copy number of the plasmids. 880ng pWA370 was mixed with 
2.2ul P3000 reagent (Lipofectamine 3000 kit) in 50ul Opti-MEM medium. Similarly, 
800ng PWA371 mix with 2.2ul P3000 reagent (Lipofectamine 3000 kit) in 50ul Opti-MEM 
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medium. Vortexed shortly two vials of DNA/P3000 mixture with 3.3ul L3000 
(Lipofectamine 3000 kit, premix with another 50ul Opti-MEM medium) respectively. For 
both plasmids, incubated for 15 minutes under room temperature and aliquots into 3 
different wells following titration manner (60ul, 30ul, 10ul) in 24-well plate. Then, added 
500ul 3T3 cell suspension (1.2 X 10^5/ml) into corresponding wells which had transfection 
complex and gently shook the plate to evenly seed cells. We also included a GFP control 
plasmids which had similar size and show good transfection efficiency.  Within 3 different 
plasmids amount (300ng, 150ng, 50ng), 50 ng was the most the optimal condition which 
clearly showed pWA371 (GCless) had significantly higher expression profile, while higher 
plasmids amount might saturate the expression and could not be differentiated obviously. 
The transfected cells rinsed with 1XPBS and were fixed for 5 minutes in 4C, which was 
followed by 2X washing in again 1XPBS at room temperature. Overnight staining was 
carried out in staining solution. Fixative contained 2% formaldehyde and 0.2% 
glutaraldehyde. The staining solution contained 5mM K-ferricyanide, 5mM K-
ferrocyanide, 2mM MgCl2, and 1mg/ml X-gal.   
Mice 
WT and transgenic mouse lines were maintained in the C57BL/6J (B6) background.  Mice 
were housed in well-ventilated cages. In maximum, up to five adult mice per cage was 
allowed. They fed on quality-controlled standard pellet chow and pure water ad libitum in 
a regular 12-hour light/dark cycle at room temperature. Wild type variants or C57BL/6J 
(B6) were initially purchased from Jackson Laboratory. H1t-SB100X mice were generated 
in C56BL/6N background at Max Delbrück Center for Molecular Medicine, Germany. 
LacG and LacZ are generated by traditional pronuclear microinjection protocol by Cyagen 
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Biosciences Inc., US. Rosa26 sense and Rosa26 antisense lines were produced with gene 
targeting (homologous recombination) method by Cyagen Biosciences Inc., US. Z/EG 
mice (Novak et al., 2000) (JAX stock 3920) were procured from Jackson laboratory as 
well. Mov10l1+/−mice (Zheng et al., 2010) were gifted by P. Jeremy Wang, University of 
Pennsylvania, PA, through Phillip Zamore at University of Massachusetts Medical School, 
Worcester, MA. Mov10l1+/−mice were crossed with transgene positive animals to generate 
Mov10l1 knock out a mouse in two steps of breeding. 
Real-time PCR 
 
SYBR-Green I master mix (Applied Biosystems) was used to perform Real-time PCR or 
quantitative PCR reactions in triplicate with 10ng cDNA template in 25ul of reaction 
volume. Q=E^(Min(mean Ct of all samples)-Ct) formula was used to calculate relative 
quantity (Q) of a specific transcript. E and Ct represent mean PCR efficiency and threshold 
cycles, respectively. Mouse Gapdh gene was used as internal control, and also no template 







Table 2.1 The primer pairs used for the genotyping of the transgenic lines. 
 
Droplet digital PCR 
 
Bio-Rad protocol was followed for running the Droplet Digital PCR (ddPCR) reactions, 
containing approximately 60ng of gDNA and fluorescence probe in reaction volumes. Each 
well of the reactions contained 60ng of gDNA. Droplet generation step was preceded by a 
step of DNA digestion with 10U/ul of NcoI (NEB) at 37C for 15 minutes. An eight-well 
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Bio-Rad DG8 droplet generator cassette was used for carrying out droplet generation step. 
Each well of this cassette was using 20ul of sample added with 40ul of droplet oil. The 
generated droplets underwent through a PCR cycling condition: 95C for10min, (94C for 
30sec, 60C for 1min) x 40 cycles, extension temperature of 98C for 10min. QX200 droplet 
reader was used to read the fluorescence signals from each droplet. Later, the result was 
analyzed with the help of Bio-Rad Quantasoft software version 1.3.2.0. The primers are 
listed below in Table 2.1. 
 
Ligation mediated PCR (LM-PCR) & sequencing of the amplicon 
 
Steps in Ivics, et al. 2011, Nature Protocols was used to get the amplicons, using the PCR 
reaction protocol described in the table. The DNA sequence was (agarose 1%) get cut and 
purified, using QIAquick PCR Purification Kit (QIAGEN). The amplicons were Sanger 
Sequenced by Eurofins Genomics. Each sequencing result was visualized with FinchTV 
(version 1.4) software for Windows.  
 
BLAST 
A basic local alignment search tool (BLAST) or BLAST-like alignment tool (BLAT) was 
used to search for the DNA sequence directly flanking the transposon, at the University of 
California, Santa Cruz (UCSC) Genome Bioinformatics website 
(http://genome.ucsc.edu/cgi-bin/hgBlat) or the National Center for Biotechnology 
Information (NCBI) website (http://blast.ncbi.nlm.nih.gov/Blast.cgi). 
 
Genotyping PCR & Locus Specific-PCR (LS-PCR) 
Genotyping of the mice was performed with gDNA mainly from their tail biopsies. A PCR 
reaction using ExTaq or ExTaq HS polymerase was run for the detection of the presence 
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or absence of expected transgene with the set of specific primers designed onto the 
respective transgene sequences (Table 2.2a). 
 
Locus Specific-PCR (LS-PCR) or junction PCR uses the primers designed to amplify the 
location between the transgene and the genomic DNA. The primers were designed with 
MacVector software Table 2.2b. It used the following conditions and PCR protocols to get 
the expected band. 
 











C min/s  
94 3min  
94 15sec  
57.5 30sec 35cyl 
72 1 min  
72 7min  
 
LacG WA0572, WA0573 311 bp 
 
H1T WA0440, WA0441 200 bp 
 
Z/EG WA0679, WA0680 173 bp 
 
Table 2.2a Desired length of the amplicon in the genotyping PCR. 
 
 
Lines Primer pairs to get 
the transgenic band 
PCR protocol Expected bands 
LacG082 WA0984 - WA0598 LSPCR 510bp 
 
LacG221 WA0988 - WA0598 LSPCR 500bp 
 





LacG071 WA0649 - WA0598 LSPCR touchdown 500bp 
 
LacG141 WA1529 – WA0598 LSPCR 508bp 
 










Cycle # Denature           Anneal           Extend  Hold 
1  94°C, 5 min   
2-31  94°C, 1 min            55°C, 30s           72°C, 30s  
32                  72°C, 7 min 
33           4°C 
LSPCR touchdown 
Cycle # Denature  Anneal             Extend  Hold 
1  94°C, 5 min   
2-11  94°C, 1 min  65°C, -1°/cycle, 30s          72°C, 30s  
12-36  94°C, 1 min  55°C, 30s           72°C, 30s 
37                 72°C, 7 min 
38           4°C 
 
LMPCR 1 
Cycle # Denature  Anneal            Extend  Hold 
1  96°C, 2 min   
2-11  92°C, 40s  60°C, -1°/cycle, 40s        72°C, 2 min  
12-36  92°C, 40s  50°C, 40s         72°C, 1 min 
37               72°C, 10 min 
38           4°C 
LMPCR 2 
Cycle # Denature  Anneal               Extend  Hold 
1  96°C, 2 min   
2-7  92°C, 40s  60°C, -1°/cycle, 40s         72°C, 1 min  
8-21  92°C, 40s  59°C, 40s          72°C, 1 min 
37                72°C, 10 min 
38           4°C 




In general, for genotyping, gDNA was isolated from tail biopsies, using the Gentra 
PureGene Tissue Kit (Qiagen). Mouse tissues were collected from animals between 1 week 
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–18 months of age, and a section of all trimmed organs, from the mice of all ages, was 
always kept stored in RNAlater (Sigma) for methylation analysis or DNA needed for 
ddPCR. The gDNA from these tissues (weighing, 10mg) was extracted using either 
DNeasy Blood & Tissue Kit (Qiagen). In some cases, where extracting gDNA from the 
paraformaldehyde tissues was essential, after cell lysis step, the lyse was further treated in 
the high heat of 95C for 30 minutes to break the peptide cross-linkages before using it for 
further steps of Gentra PureGene Tissue Kit (Qiagen). 
 
Tissue harvesting and preparation 
Animals were euthanized with isoflurane. Immediately after the respiratory arrest, the 
diaphragm was cut to expose the liver. Later, the diaphragm was first to cut laterally across 
and again cut on both ends of diaphragm across the ribs and towards the head to expose 
the heart. A needle of the winged infusion set (19 Ga) connected to a peristaltic pump with 
a tube inserted the catheter needle into the protrusion to extend up approximately 5mm 
inside the ascending aorta. The right ventricle of the heart was cut open with a sharp scissor 
for drainage of blood.  First, 1× PBS flowed slowly but constantly until the liver got pale. 
Next, the fixative used to perfuse the heart. Neonatal animals were perfused with 18ml of 
either 1XPBS or 4% PFA without additives (duration: 3min; flow rate: 6 ml/min), and the 
adult and aged mice were perfused with 36ml of either 1XPBS or 4% PFA without 
additives (duration: 4min; flow rate: 9 ml/min). 
 
Next, the organs were individually collected into cold 1XPBS for clearing of any blood. 
The organs, except the brain, were then trimmed according to the desired orientations 
(Table 2.4) mentioned in the work by Ruehl-Fehlert et al. in 2003 (Ruehl-Fehlert et al., 
2003). Next, the tissues were drop-fixed into 2% PFA with additives for neonatal organs 
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for 4 hours or into 4% PFA with additives for neonatal organs for 6 hours under constant 
agitation. Later, washed for 40min in 1XPBS for 2 times (each for 20min). Dropped into 
15% sucrose solution at 4C until they dropped. When dropped again put into 30% sucrose 
solution until they dropped again. The organs were soaked for the water out and were 
equilibrated in OCT not more than 15 - 20 mins. The tissues were then rightly oriented, 
being in steel made tissue embedding molds, before snap freezing in liquid nitrogen. The 
snap freezing was carried on an iron/steel base immersed into liquid nitrogen and with the 
OCT molds placed onto the base. The OCT blocked were packed in zip bags individually 
and stored at -80C until use.  
 
Organ Localization Direction 
Brain Sagittal  Longitudinal 
 
Heart Through ventricles and atria Longitudinal 
 
Lung Left lobe Longitudinal horizontal 
 
Liver Left lateral lobe Transverse 
 




Spleen At largest extension Transverse 
 
Testis Close to rete testis Longitudinal 
 
Table 2.4 Organ-specific orientations used during the trimming of the tissues. 
 
Cryosectioning and X-gal staining of fixed tissue 
Before beginning, it was made sure that the OCT blocks are at -20C at least 20-30 minutes 
before sectioning. Tissues were sectioned in a thickness of 20um for X-gal staining and 
14um for immunostaining. The microscopic slides were dried in air for 15-20 minutes. The 
slides were washed in 1X PBS for 5min at 4C, incubated in 1% PFA solution for 5 minutes 
at 4C, and left in 1XPBS at 4C until next step. Washed with freshly prepared LacZ wash 
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solution for 15-20 minutes on a rocker. Incubated for overnight (14-16 hours) for all lines 
(except, Rosa26 antisense line and slides for subsequent immunostaining) or at 37C, being 
immersed into freshly prepared X-gal solution (adjusted to required pH) with a casual 
covering. Took the slides out of the incubator. Rinsed with water. Washed for 20 min in 
total in 1XPBS (2 times for each 10 min) under agitation. Post-fixed in 1% PFA for 5 mins 
in RT. Washed with 1XPBS for 10 mins. Rinsed with water. Counterstained with freshly 
prepared neutral red for 7 min with intermittent shaking. Rinsed with water. Dehydrated 
for 3 mins each in 70%, 90%, 100% ethanol. Dried shortly and add EcoMount and 
coverslip. Stored at room temperature or 4C in a slide holder box. Looked under the 
microscope. 
Preparation of 4% PFA fixative without additive (25ml) 
Added 1g of PFA to 15ml of autoclaved, stirring the water at 60C (waited for 15mins). 
Added 5ul of 5M NaOH to get it dissolved (waited 15 mins). Added 2.5ml of 10X PBS. 
Added autoclaved water to volume up to 25ml.  
Preparation of 1% PFA fixative with additive (100ml) 
1% PFA                                    25ml of 4% stock  
2mM MgCl                                   200ul from 1M stock  
5mM EGTA pH8.0                       4.4ml from 0.1136M stock (solvent: 
water)                                                             
0.2% NP-40                                   2ml from 10% stock (solvent: water)  
10X or 0.1M PBS                        10ml  
Autoclaved water                                   Rest of the volume  
Preparation of LacZ wash solution (100ml)    
2mM MgCl2                                   200ul from 1M stock (solvent: water)  
0.01% sodium deoxycholate           100ul from 10% stock (solvent: water) 
0.02% NP-40                                   200ul from 10% stock (solvent: water) 
1XPBS                                      rest of the volume   
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Preparation of LacZ stain solution (or Xgal solution) (10ml)      
Xgal stock                                  400ul of LacZ stock (25mg/ml) 
5mM Potassium ferricyanide         16.5mg  
5mM Potassium ferrocyanide         21.1mg  
LacZ wash solution                       9.6ml  
  
Detailed information regarding regents used 
Chemical Manufacturer Reference Code(s) 
X-gal  Cayman Chemical Item# 16495;  
Batch# 0532100-17 
PFA Sigma-Aldrich Ref.# P6148; 
Lot# MKCD5278 
Neutral red Sigma-Aldrich Ref.# 72210;  
Lot: BCBP6989V 
NP40 or IGEPAL Sigma-Aldrich Ref.# I3021; 
Lot:MKBC8185V 
Sodium deoxycholate ACROS Ref.# 218590250 
Lot#A0293327 




EMD Chemicals Ref.# 5980 
Potassium ferrocyanide Sigma-Aldrich  Ref.# P3289 
Potassium ferricyanide Sigma-Aldrich Ref.# 244023 




Size: 25x 75 x 1.0 mm 
Fisher Scientific Cat.# 12-550-15 
Cover Glass Fisher Scientific  Ref.# 12545F;  
Lot:18838 
 
Preparation of neutral red counterstain  
500mg of neutral red was stirred in 100 ml of deionized water for overnight. 
Later 1 drop of acetic acid was added.    
IF staining followed by X-gal staining 
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Fourteen um thickness of the brain samples were sectioned. Dried for 15-20 
minutes in the air. Immersed in 1XPBS for 10 minutes. Fixed for 5 mins in 1% 
PFA. Stored in 1XPBS at 4C until further use. Washed in LacZ wash solution for 
15 minutes. Stained with X-gal solution (25mg/ml; pH 7.7) for 5 hours at 37C. 
Wash with 1XPBS for 15-20 minutes under agitation. Antigen retrieved for 10 
minutes at 90C in 1X Na-citrate buffer. Waited for the solution to cool down, and 
avoided to take the slides out when the solution is hot. Rinsed in water. Incubated 
for 1 hour in blocking buffer containing serum and 0.2% Tween-20, 1% BSA, 5% 
donkey serum in 1XTBS at RT. Overnight incubated with blocking buffer with a 
required ratio of primary antibodies in antibody dilution buffer, containing 0.2% 
Tween-20 and 1% BSA. Incubated at RT with 1xTBS with only 0.2% Tween-20 
for 5 minutes for 3 times. Incubated with the secondary antibody in antibody 
dilution buffer for 2 hours at RT. Incubated at RT with 1xTBS with only 0.2% for 
5 minutes for 3 times. Incubated at RT with DAPI in water for 5 minutes. Dried 
and added Prolong antifade mountain agent before putting on the coverslips. 
Primary Antibodies 










Thermo Scientific Ref.: 62248 
 
Other reagents 
Bovine serum albumin (heat-shock 
treated) 
Fisher Bioreagents CAS 9048-46-8 









   
Bisulfite-sequencing analysis 
Total gDNA was extracted from tissues of mice, using DNeasy Blood & Tissue Kit 
(Qiagen) manufacture’s instruction. Bisulfite conversion of the gDNA was performed by 
using the EpiTect Plus DNA Bisulfite Kit (Qiagen). Nested PCR was set up using Ex-Taq 
Polymerase (Takara). MethPrimer (http://www.urogene.org/cgi-
bin/methprimer/methprimer.cgi) was used to design the bisulfite PCR primers shown in 
table 2.5 (Li and Dahiya, 2002). The amplicons were gel-purified using the QIAquick Gel 
Extraction Kit (Qiagen) followed by cloning into a TA vector (Stratagene). In a blue/white 
colony screening, the white bacterial colonies were chosen for Sanger Sequencing. To get 
the DNA methylation status, the sequence data were analyzed with the help of a 
quantification tool for methylation analysis, QUMA (Kumaki et al., 2008) 
(http://quma.cdb.riken.jp/top/quma_main_j.html). QUMA gave methylation plots, which 
were next downloaded.  
LacZ WA1299, WA1300 (expected band at 526bp) 
 
LacG WA1301, WA1302 (expected band at 506bp) 
 
Table 2.5 The primer pairs used for bisulfite sequencing of the transgenic lines. 
 
Microscopy and image analysis 
In general, Zeiss Axio Imager Upright microscope was used to take regular fluorescence 
and bright-field images of different magnification of X20 or X40. Aperio VERSA Bright 
field Fluorescence & FISH Digital Pathology Scanner (Leica, NJ) was used to scan the 
whole-slide bright-field images of the stained sections at maximum 20X resolution. These 
whole-slide images (extension .SCN) were navigated with the help of Aperio ImageScope 
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(version 12.4.0.5043), a pathology slide viewing software, from Leica Biosystem, Leica, 
NJ. 
QuPath 
The signals from bright-field or immuno-stained images were quantified with QuPath 
(version 0.1.2) to quantify the percentage of positive cells with the required signals. The 
file extension of the original, whole-slide images (.SCN) was not compatible with the 
QuPath. Therefore, the images were converted to .TIF output (compression mode ‘LZW’) 
with the help of image extract option in Aperio ImageScope (version 12.4.0.5043). The 
interesting area(s) of the tissue sections were manually annotated to let QuPath perform 
quantification based on the manual or pre-written scripts with the necessary instructions.  
 
QuPath: quantification of signals 
Two image types in the program QuPath were used for quantification: brightfield (H-DAB) 
for X-gal stained tissues and fluorescence for immunofluorescence tissues. For the X-gal 
stained tissues, a different script was created for each tissue based on its specific 
characteristics. Each script was modified using a certain number of channels. Each channel 
denoted a specific command to either denote a cell as either positive, negative, or border 
based on the intensity of the hematoxylin or DAB. The mean, sum, and max intensity of 
these two parameters were optimized over a range of several tissues to accurately detect an 
X-gal positive cell from a negative. A percentage was then derived by taking the number 
of positive cells divided by the number of negative cells plus positive cells and then 
multiplied by 100. The cells detected as border were determined to be falsely detected cells 
and were not included in this equation.  
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QuPath Data Plot 
The QuPath data were plotted using the ggplot2 package of the R software (version 3.6.2). 
For any tissues with no detected X-gal positive cells, we plotted 1/(total number of cells) 
since we could better see the data points (there would be too much clutter if we had plotted 
them all as 0's). To make it clear that these data were referred to tissues with no detected 
X-gal positive cells, we also created a binary column called Detected, which had a value 
of "Yes" or "No". To further reduce the clutter, we used the position jitter function so that 
there was less overlap between data points. We also used the log10 scale for the y-axis 
since the range of y values (percentage of X-gal positive cells) is very small (0 to about 10 
percentage). Thus, using the log10 scale improved the visual by "stretching out" the y-axis 




Statistical analysis and mathematical calculations were performed using either Microsoft 
excel. Sample means were compared with the help of two-tailed unpaired T-test used and 
expressed in terms of the p-value. Analysis of replication consistency was tested with 
Coefficient of variation (CV %) was used to analyze replicate consistency. Any CV values 
with <100% were regarded to have data with less variation. 
 
2.4 Results 
2.4.1 Development and preliminary testing of LacZ based reporter transgenes for L1 
promoter activity  
To understand the in vivo promoter activity, the endogenous 5’-UTR promoter was fused 
with either of the two reporter genes (Fig. 2.1a). The in vivo expression from these two 
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transgenic constructs was analyzed in the transgenic mouse, with wild-type (C57BL/6) 
genetic background, carrying the same transgene in a unique chromatic location. 
Before generating transgenic mouse lines, we analyzed in vitro the transient expression 
patterns of these two constructs in transfected mouse embryonic fibroblast cell line (3T3). 
Here, we found a significant difference of expression in these two transgenic constructs, in 
the presence of appropriate control with GFP plasmid (Fig. 2.1b). Transfection with a 
plasmid (pWA370), enclosing 5’UTR-LacZ transgene, generated about 2.5 fold less X-gal 
positive cells than that of its counterpart plasmid (pWA371), which carries 5’UTR-LacG 
transgene. In vivo differences of their expression patterns in locus-dependent as well as 
time-dependent manner were also determined in sections 4 & 5.  
a. Sketch of our transgenes  
 
 
b. 3T3 cells transfected with plasmids (pWA370 & pWA371) 
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300 ng   (GFP control)                              10X 50 ng  (GFP control)                          10X 
5’UTR-LacG (50 ng of pWA371)        10X                      5’UTR-LacZ (50ng of pWA370)      10X 
Figure 2.1. LacZ and LacG transgenes (a) sketch of the structure of LacZ and LacG 
transgenes & (b) The transfection results in the 3T3 cells with the plasmids carrying the 
transgenes. 
 
2.4.2 Generation of transgenic mouse lines each carrying a single-copy 5’UTR-LacG 
(or 5’UTR-LacZ) transgene at a random genomic locus 
To obtain single-copy germline insertions for our transgene, the donor animal was bred 
with H1t-SB100X positive transgenic animals (Grandi et al., 2015), expressing a 
hyperactive Sleeping Beauty (SB) transposase specifically in pachytene spermatocytes 
(Mates et al., 2009). Therefore, the excision of the transgene and their successive 
mobilization happened in male germ cells, carrying both H1t-SB100X and the L1 transgene 
(Fig. 2.2).  
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Figure 2.2 Generation of single-copy mouse lines with the Sleeping Beauty DNA 
transposon system 
 
The progenies of this male with a wild-type female possess differential copy numbers of 
transgenes. The transgenic mice with low-copy or single-copy number were identified, 
using real-time PCR and droplet digital PCR, respectively. Next, the loci of these 
transgenes were mapped (Fig. 2.3), and primers were designed for locus-specific PCR at 
the junction of the transgene and genomic DNA. On some occasions, when the transgenes 
moved further due to the presence of H1t-SB100X in the transgene positive animals, the 
mobilization was detected with the help of the result of locus-specific PCR. In those cases 
of a new position, the transgene was again mapped. A pedigree was maintained for these 
single-copy animals (Fig. 2.4). 
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Mapping protocol (adopted from Ivics et al., 1997) 
 
A sample LMPCR-2 gel  
    
 Sequencing data of gel cut 
 
Mouse Blat result            
 
Figure 2.3 Steps to detect the single-copy mouse from the ones with high copy tandem 
repeat, using techniques like (a) Real-Time PCR, (b) ddPCR, (c) gene mapping protocol, 




   
 









                                                     
    




   
d.  
Figure 2.4 Detection of transgenic loci for the sublines. (a) Design of primers for locus-
specific PCR, using the BLAT results, (b) Sample of gels with expected bands from three 
sublines, (c) a prototype of pedigree maintained for the single-copy mice, and (d) a list 
specifying the details of the mapping result for the sublines. 
 
2.4.3. X-gal staining to detect 5’UTR-LacG or 5’UTR-LacZ transgene 
expression in mouse tissues in situ 
In this part, X-gal staining for the cryosections was validated and optimized. As the 
cryosections were X-gal stained and followed by counterstain with neutral red. We 
observed the X-gal signals being colocalized with neutral red (Fig. 2.5.a) under light 
microscopy. Upon immunostaining of the X-gal stained sections, we observed the blue 
stains surrounded by lamin B signals (Fig. 2.5.b). This added to the 2nd line of verification 
of our X-gal stains. Later, we optimized pH of the X-gal solution to an optimum point 
which is suitable to eliminate the signals from endogenous beta gal if present in any tissue. 
We use Z/EG transgenic mouse as a control. We also found that at pH 7.7, ZE/G kidney 
maintained a substantially intense X-gal signal (Fig. 2.6). 
The optimum level of fixation of tissues in fixative is necessary for an ideal X-gal staining 
at determined pH. Additionally, a perfect fixation condition would provide us with a better 
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morphology of the tissues in the shortest period, retain the maximum β-gal from a time-
dependent degradation, and prevent over-fixation of tissue to guarantee maximum stain. In 
neonatal time point, we observed that drop-fixation condition with 2% PFA with additives 
for 4 hours turned out to be the best condition with the shortest period and with using the 
lowest concentration of fixative possible (Fig. 2.7). On the other hand, at an adult time 
point, the longer time and higher concentration of fixative – i.e. 6 hours into an additive-
mixed 4% PFA solution devoid of glutaraldehyde - were essential to stain the tissue 
samples (Fig. 2.8). Notably, in both of these time points, control Z/EG tissues were used.  
Finally, desired staining patterns, which matched with their corresponding genotypes, were 
attained for all five genotypes used in this study (Fig. 2.9). Next, the whole slide scanned 
images of the tissue sections obtained from different lines in various context, we quantified 
the X-gal signals using the QuPath software. It uses a machine learning approach to bio-
analyze the whole slide images. This allows a user to teach QuPath how to distinguish 
individual cells by separating stains and also determining the intensity peaks for either 
neutral red, X-gal, or both (X-gal positive cells) within a marked annotation (Fig. 2.10). It 
was possible to make the detections fully automated using scripts. 
a. Validation with neutral red 
 
b. Validation with immunostaining with Lamin B antibody 
40X N573 (Brain), 20X 
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N573 (Brain); X-gal (Brightfield x20) 
 
N573 (Brain); Lamin B (FITC, X20) 
 
N573 (Brain); DAPI merged with X-gal 
(BF) , X20 
 
N573 (Brain); Lamin B (FITC) merged 
with X-gal (BF), X20 
Figure 2.5: Validation of X-gal signals. (a) Validation with neutral red co-staining. (b) 




   
 
Figure 2.6 A pH gradient (7.5, 7.7 and 8.5) of X-gal solutions was used to stain adult 
kidney sections from the non-transgenic mouse as well as Z/EG mouse. 
 
Neonatal kidney of Z/EG mouse 
 
6 hours in 4% PFA 6 hours in 2% PFA 
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4 hours in 4% PFA 
 
4 hours in 2% PFA 
Figure 2.7: In search of a suitable tissue fixation condition, different combinations of 








Adult kidney of Z/EG mouse 
 
6hr (4%PFA + additives) + glutaraldehyde 
 




   
 
4hr (4%PFA + additives) + glutaraldehyde 
 
 
4hr (4%PFA + additives)- glutaraldehyde 
 
Figure 2.8: In search of a suitable tissue fixation condition, different combinations of 






ZEG positive (ZEG070), Brain(Thalamus) 
 




   
LacG positive (N573), Brain ( Thalamus) 
 
LacZ positive (N483), Brain (Thalamus) 
Figure 2.9: Desired staining patterns matched with their corresponding four genotypes 
used in this chapter. 
 
 
Figure: 2.10 Detection of X-gal positive cells using QuPath. Here, Original column, 
corresponding to each organ shows original stained tissues. When these regions were fed 
in QuPath for quantification, the detections were shown to be annotated accurately with 





   




Figure 2.11 In vivo promoter activity of 5’UTR fused with WT-LacZ sequence, being 
placed in three random genomic loci at three different time points. 
 
Neonatal time point has detectable signals only in brains (of 2 out of 10 animal for all three 
lines) and kidneys (of 3 out of 10 animals for all three lines). For kidney, all 3 of 10 animals 
belonged to one particular line, LacZ0163. For the brain, 2 of the 3 detectable values were 
from another particular line, LacZ0163. However, in other neonatal organs, there are no 
detectable signals. The highest level of detectable expression for the neonatal brain was 
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0.003%, and for kidney, it is 0.06%. On the other hand, at an adult time point (aging 2 
months), several organs showed to have detectable values, namely lung, kidney, spleen and 
testis (Fig. 2.11). 
Finally, most of the old animal (aging 12 – 18 months) brains had a detectable range of 
values of around (Fig. 2.11). Among 10 animals, 2 were undetected with a detectable range 
of 0.001- 0.04%. Kidney and testes consistently have the highest level of expression at the 
old-time point. In the case of the kidney, 3 of the 4 highest values are coming from a 
particular line, LacZ0161. In the case of the testis, 2 of the top 3 highest values are coming 
from a particular line, LacZ0160. In spleen, lung, liver, and heart, however, showed 
minimum expression. 
Among the three time points, the highest value of the percentage of the X-gal positive cells 
is still below 1%. Heart, liver, & lung showed the most number of undetectable signals, 
say 19 out of 21, or ~90 % of animals showed no signals in the heart. Twenty-two out of 
23 animals i.e. ~95 % of animals showed no signals in the liver, whereas out 20 of 22 
animals, or in other words, ~90 % of animals showed no signals in lungs. Most signals are 
undetected in neonatal and adult (Fig. 2.12); however, the most number of detectable 
signals were found at aged animals. In all three lines, during the old-time point, kidneys 
and testes showed a consistent expression pattern. Moreover, the kidney also showed the 
highest number of expression in old animals. Among three lines, LacG0160 showed 
comparatively lower expression in kidney than the other two lines, whereas LacZ0161 




   





























































                                        
G0437 (Testis) 





   
Figure 2.13 showed few of the histological locations on the tissues, where X-gal stains 
were found to be present relatively more in number in some of the organs across three 
different time points. Interestingly, some of these animals were litter-mates of the animals 
showed in the above panel. In testis, X-gal positive cells lied at the border of the 
seminiferous tubules. In brain and kidney sections belonged to neonatal and old, X-gal 















Figure 2.13 Substantially (X-gal) stained LacZ tissue sections at 20X (labelled the 








   




2.4.5.1 Expression level during a neonatal time point  
2.4.5.2 Expression level during an adult time point  
2.4.5.3 Expression level during a geriatric time point  
2.4.5.4  Kidney showed as the most common preferential organ with the highest number 
of promoter activity among four lines across different developmental time points 
2.4.5.5 Heart showed the highest signals but they are uncommon 








   
 
Figure 2.14 The promoter activities (in percentage of positive cells) in different neonatal 
organs of all sublines belonged to LacG line. (a) Line-wise (b) organ-wise distributions. 
 
The expression in brain varied across the lines with a least detectable value at 0.003% to 
highest being at 0.6%. LacG071 is the highest expression in the brain, where the individual 
values varied highly. Heart values were highest among all the tissues. LacG071 showed 
the highest activity among the heart values in an average. However, in the heart, many 
positive signals were not localized in the nuclei. This will be separately reported in the next 
section below. No detectable values were found in spleen and testis. Expression values 
fluctuated a lot in most of the organs. LacG071 and LacG061 showed most expressions of 
high values. Livers & lungs had detectable expressions. In testes, no detectable values were 









   
2.4.5.2 Expression level during adult time point  
 
 
Figure 2.15 The promoter activities (in percentage of positive cells) in adult (56 days 




LacG071 has the highest numbers of X-gal positive cells (i.e. ~1-2%) in the brain with 
less standard deviation (Fig. 2.15). Heart again has leading values in all lines, and the 
levels of these values are comparable to brain and kidney. Liver, lungs and spleen had 
a low profile, but LacG082 had no signal in the liver. Unlike neonatal time points, 
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spleens and testes have detectable values in adult time points. Testes have most 
detectable values in LacG071. 
 
2.4.5.3 Expression level during geriatric time point  
 
 
Figure 2.16 The promoter activities (in percentage of positive cells) in old animals’ 
organs of all sublines belonged to LacG line. (a) Line-wise (b) organ-wise distributions. 
 
 
At this time point (Fig. 2.16), some of the new lines included which were not 
represented earlier in two-time points. LacG066 had the highest level of expression in 
the brain (4%), disregarding heart with >10% of positive cells. A comparative level of 
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expression was observed in LacG071 line, however, with at least 10-fold difference 
among individual mice. Kidney has the highest level of expression in LacG066 among 
all samples and all lines. Values from kidneys were comparable to the values from the 
heart in terms of magnitude. Liver and lung showed low profile. Testes values increased 
quite significantly as compared to the adult time point.  
 
2.4.5.4 Kidney showed as the most common preferential organ with highest number 
of promoter activity among four lines across different developmental time points 





























Table 2.6: The organ had the highest expression in different lines 
 
Above table (Table 2.6) summarizes the organs that were found to have the highest 
mean of the expressions in three-time points across four random lines. Following 
histograms (Fig. 2.17) are showing different mathematical values supporting the table 
above. In histograms, the y-axis is the percentage (%) of positive cells and x-axis is 
different organs. Here we see, out of 4 unique organs in this table (brain, lung, kidney 
and testes) across 4 different lines, the kidney is seemingly the most preferential organ 
for high promoter activity among all the time points. Spleen seemed to be the lowest 
expressive organ. Heart values were also excluded from this comparison. Substantial 
standard deviation was observed. LacG082 line showed the lowest level of expression, 
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where expression was silent in almost all tissue. LacG071 line showed the highest level 
of expression in brain, kidney and testes. 
 
 
Figure 2.17 Histograms showing average promoter activity (%) in different main organs 
across four different lines. 
 
2.4.5.5 Heart showed the highest signals but they are uncommon 
In all time points of LacG lines, many granulated, non-nuclear localized X-gal positive 
signals have been observed, which, in turn, increased the positive signals in the heart. 




   
Heart signals in LacG lines 
LacG positive  LacG negative  
 
LacG071/ N574 (LacG+), Heart 10X 
 
LacG071/ N807 (LacG-), Heart 10X  
LacG061/ N617(LacG+), Heart 10X LacG061/ N710 (LacG-), Heart 10X 
 
LacG082/ N583(LacG+), Heart 10X LacG082/ N626 (LacG-), Heart 10X 
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LacG221/ N603(LacG+), Heart 10X 
 
LacG221/N601(LacG-), Heart 10X 
Figure 2.18 Uncommon x-gal signals in heart of LacG positive animals vs LacG 
negative animals 
 
2.4.5.6 Drastic change of expression was noticed upon moving of transgene to a new 
locus 
 
During the transition from 2nd generation to the 3rd generation, transgene moved from a 
mapped locus point of LacG066 (Chr. 15) to a new location of LacG221 (Chr. 14). More 
specifically, the only survived animal belonged to LacG066, N066, was a transgenic parent 
of the founder of LacG221 line. At the old stage, a drastic change of expression was noticed 
in the brain and kidneys of N066 in compared to the same of the progenies of LacG221. 
The former showed the highest load of positive signals ever noticed in any animals of LacG 
lines. On the other hand, a minimum expression was observed in the tissues of animals of 
comparable age belonged to LacG221 line (that includes N395 and N425 as aged members) 
(Fig. 2.19).  
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N066, Kidney  X10 
 
N066, Cerebellum X10 
 
LacG221/N395, Kidney  X10 
 
LacG221/N395, Cerebellum X10 
 
LacG221/N425, Kidney  X10 
 
LacG221/N425, Cerebellum X10 
Figure 2.19: The contrast between the x-gal signals in kidneys and cerebellums of 






















   
2.4.6. LacG071: The line with high transgenic expression in most of the 
tissues at all time points 
Contents: 
2.3.6.1 The promoter activities in different organs of LacG071 varied across three 
developmental time points 
2.3.6.2 Brain regions of LacG071 have heterogeneous activity pattern  
2.3.6.3 Thalamus is the most common preferential region for promoter activity 
across different random lines 
 
2.3.6.1 The promoter activities in different organs of LacG071 varied across three 
developmental time points 
 
 
Figure 2.20 The promoter activities in different organs of LacG071 varied across three 
developmental time points  
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Brain, heart and kidney showed high expression (Fig. 2.20). With less standard deviation 
(coefficient of variation (CV) %= 62.82, around 1% of the brain cells showed positive 
signals in adults, unlike other two time points. While, the liver, lungs and spleen showed a 
low promoter activity. No detectable value was found in the spleen during neonatal time 
point; however, in some adult individuals, the average value is 1 positive cell per 10,000 
cells. Interestingly, no signal was detected in testes at a neonatal time point, but signal level 
consistently kept rising in subsequent ages, adults and aged. The above result was 
















   
 









































   




Figure 2.22 L1 promoter activity (%) in different brain regions of mice belonged to 
LacG071 line 
 
At Neonatal of LacG071 
At the neonatal time point of LacG071, thalamus showed the highest values in at least two 
animals out of four in total. The average values from all four animals were 0.44%, which 
is the highest among all other averages from other regions for this time point. 
 
At the adult time point of LacG071 
In adult animals of LacG071, out of four animals, three animals showed very high signals 
in the hippocampus, showing a definite expression in the dentate gyrus (Fig. 2.23). One 
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specific animal, N522, showed a high level of X-gal signals in the cortex (16.56 %) and 
hippocampus (14.07 %) of all adult stage animals. Except the mentioned, outlying values 
of N522, first and second most expressive regions were thalamus and Hypothalamus 
respectively. However, wide variability was observed in thalamus values among the 
animals (CV% = 118.46).  
At the old time point of LacG071 
Average values from thalamus fell back sharply during older age from a peak state of adult 
time point. However, this region still leads in the average transgenic expression among the 
old animals and ties with the cortex value. A drastic change of falling of hippocampus 
value is a worth taking attention. 
Very interestingly, adult time points showed consistently the highest average levels of 
positive signals in all brain regions of LacG071. Cerebellum showed minimum expression 
in all-time points of LacG071 line. Overall, with the change of developmental time point, 
sharp fall and rise of the expression were observed in hippocampus, cortex, hindbrain, 
hypothalamus, and thalamus values (also in Fig. 2.27). Thalamus was the most common 
region for the promoter activity in all-time points of the LacG071 line (Fig. 2.23 and Fig. 
2.27). A specific expression pattern along the dentate gyrus of the hippocampus in all-time 












   
 Transgenic expression in the 
dentate gyrus 




N574 (Brain, Hippocampus) 
 
N804 (Brain, Thalamus) 
Adult 
 
N795 (Brain, Hippocampus) 
 
N524 (Brain, Thalamus) 
Aged 
 
N446 (Brain, Hippocampus) 
 
N446 (Brain, Thalamus) 
Figure 2.23: Sample images (at 10X) of all brain regions (hippocampus & thalamus) of 










   
2.4.6.3 Thalamus is the most common preferential region for promoter activity 
across different random lines 
2.4.6.3.1 Brain regions of LacG061 line 
 
Figure 2.24: L1 promoter activity (%) in different brain regions of mice belonged to 
LacG061 line 
 
Overall, the brain regions of all animals across different time point showed very low 
expression (Fig. 2.24). Hindbrain tops the list. In adults, thalamus and hypothalamus 
showed increased values in a single animal out of two. Again at the old-time point, 











   
2.4.6.3.2 Brain regions of LacG221 line 
 
Figure 2.25: L1 promoter activity (%) in different brain regions of mice belonged to 
LacG221 line 
 
In both neonates and adults, hindbrain showed detectable values in all animals. And 
among adults, one animal showed high detectable expression in the hypothalamus. 
Whereas, thalamus topped in one of the old animals as the leading value, whereas in 













   
 
2.4.6.3.3 Brain regions of LacG082 line 
 
Figure 2.26 L1 promoter activity (%) in different brain regions of mice belonged to 
LacG082 line 
 
It consistently maintained a low level of expression in all animal regardless of the time 
point. However, hindbrain leads in Neonatal, the hypothalamus in adults, and thalamus 
expression was prominent in the old animal (Fig. 2.26).  
 
2.4.6.3.4 In search of a common region(s) with the most expression: 
Among the four lines, LacG071, LacG061, LacG082 & LacG221, it was pertinent to know 
which brain area had the most expression and also whether any particular region had 
consistently most transgenic expression. The table (Table 2.7) below summarized the 
histograms (Fig. 2.27), showing average promoter activity (%) among three time points 




   





Thalamus & Cortex 
(0.35%) 



















Table 2.7  The mouse brain regions with the highest promoter activity in four different 
lines at three developmental time points  
 
Here we see, out of 5 unique regions (hindbrain, hypothalamus, thalamus, cortex, and 
cerebellum) of 4 different lines, the thalamus is seemingly the most common (as it 
appeared in 5 cases out of 14), a preferential region of promoter activity of all the time 
points, whereas hypothalamus and hindbrain take jointly 2nd position with 3 
appearances, and cerebellum, hippocampus and cortex for 1 time each only. N522 
animal particularly showed a high number of positive cells in most of the regions of its 
brain. Cerebellum showed consistently the lowest level of expression in all-time points, 
except old time point in LacG061. Hippocampus, though appeared one time but carries 
the highest value (5.03%) among all the regions been compared. Therefore, it might be 
the less preferential region of promoter activity. Here, a high standard deviation among 
the expression values was observed. Figure 2.28 is showing the data distribution of the 
animals of LacG071 sublines in three time points.  
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Figure 2.27: Histograms showing average promoter activity (%) (in the y-axis) in 










   




Figure 2.28 The variation of the values of different brain regions of LacG071 line. 
 
2.4.7 Promoter regions of LacZ and LacG transgenes are 
hypermethylated 
 
Two different tissue samples (brain and kidney) of one animal from each line were 
extracted for the DNA. The DNA was bisulfite converted, and the methylation of a part of 
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promoter region DNA was analyzed. The brain and kidney samples of LacZ line showed 
respectively 94.3% and 93.7% of DNA methylation. While LacG line showed 
comparatively higher methylation status of 97.3% and 98.2% in brain and kidney, 
respectively (Fig. 2.29a). Figure 2.29b shows that even after having so much methylation 
at the promoter site, the tissues of the sample animal showed expression in LacG line, not 





   
b.
 
Figure 2.29 The bisulfite sequencing data for DNA methylation analysis. (a) Methylation 
levels of part of the promoter of both transgenes & (b) transgene expression in the tissues. 
 
2.5 Discussion 
Vast sequence homology of endogenous LINE-1s barred us from using an appropriate 
technique to harness the locus-specific information of L1 promoter activity. Here, we 
utilized a transgenic approach to know the locus-dependent expression pattern of LINE-1 
promoter activity. 
Unlike A and F subfamilies, TF is the youngest subfamily of mouse LINE-1. With an 
abundant expression in the mouse genome, it carries 4000-500 full-length members. Due 
to having a large number of active members, it is an expanding sub-family of mouse LINE-
1. L1spa is a name of a full-length LINE-1 insertion caused by this TF subfamily, and this 
L1spa cause disease in mouse (Kingsmore et al., 1994; Takahara et al., 1996; Naas et al., 
1998). Therefore, we wanted to characterize the promoter activity of this L1spa.  
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Therefore, we fused the 5’-UTR promoter from this L1spa sequence and attached to 
LacZ/G reporter to make our transgene) (Fig. 2.1a). With the help of pronuclear 
microinjection procedure, we were able to integrate our transgene into random 
chromosomal sites.  Later, with the help of histochemical detection of the reporter 
expression, we quantified the promoter activity of the LINE-1 promoter activity. In most 
of the sublines and organs, we found a silencing effect of the transgene.  
There are several general reasons for gene silencing. Due to the influence of the sites of 
the chromosome, the stably integrated transgene are often poorly expressed (Bestor et al., 
2000, Fiering et al, 2000). Several other factors are attributed to the variation of transgene 
expression, include the differences in copy number and location of the chromosome, and 
fidelity of the transgene construct itself (Matzke & Matzke, 1998; Kooter et al., 1999) as 
well as an epigenetic factor, like position-effect variegation (PEV) and DNA methylation. 
It has already been shown that LINE-1 transcriptions have been influenced by the upstream 
gene sequences (Lavie et al. 2004).  Additionally, promoter methylation is one of the 
strongest candidates for gene silencing. In general, DNA methylation can also be inherited 
in subsequent generations (Balow, 1995; Schumacher et al., 2000; Kearns et al., 2000). 
Other candidates for gene silencing could be histone modifications or other epigenetic 
factors (Kearns et al., 2000; Mehta et al., 2009). 
In general, the position effects can be observed in two types in vitro, stable and silencing. 
In the stable category, the transgene expression is obtained pervasively in most of the cells 
in a similar manner. This expression will be essentially different from the similar transgene 
or endogenous gene, being embedded in a different site. On the contrary, the silencing 
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category involves with the heterocellular expression, where except being expressed in few 
cells, the transgene is silent normally silent (Pikaart et al., 1998; Walters et al., 1996). 
Nevertheless, a suitable detection technique to report promoter activity was needed. For 
the detection techniques, it was vital to opt for a sensitive technique, which should be 
equally sensitive and quantitative enough for in situ signal detection as well as having a 
robust screening efficiency with less experimental variations. Thereby, we chose LacZ 
reporter assay or X-gal staining. 
Originally, the LacZ gene encodes β-galactosidase in Escherichia coli. This enzyme can 
also hydrolyze different synthetic (chromogenic and fluorogenic) chemical substrates. 
Thus, X-Gal, a colorless chemical, is cleaved by this enzyme to produce a blue-colored 
compound, 5-bromo-4-chloro-indole, which is easy to detect in an in situ screening 
procedure. Therefore, LacZ fusion with a promoter of interest could be used to characterize 
the activity of a promoter in cell lines or can be used to generate a transgenic mouse line. 
Over 30 years ago, the first transgenic LacZ mice were generated (Kothary et al., 1988; 
Kothary et al., 1989).  Since then this versatile reporter gene has been used to create several 
mouse models to characterize the expression of genes and also to trace the cells lineage 
during development. This reporter assay provides an indirect measurement of promoter 
activity, yet it is a highly straightforward, time-saving, and reproducible, requiring no 
expensive reagents and equipment. 
However, bacterial-origin LacZ gene shows the CpG content of 9.24% (Chevalier-Mariette 
et al., 2003). The methylation of 5'-CpG-3' dinucleotides within genes mostly creates 
potential targets for the protein complexes that bind onto methylated DNA sequences and 
also to histone deacetylases. These bindings could lead to transcriptional repression by 
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modifying the chromatin landscape. There is evidence as methylation of non-promoter 
sequences could result in transcriptional silencing of reporter genes (Kass et al., 1997; 
Hsieh et al., 1994). 
Hence, to avoid the silencing of the promoter activity due to the methylation of the gene 
body containing the reporter cassette, a CpGless version of the CpG-rich LacZ gene (i.e., 
LacG) was engineered by eliminating the CpG dinucleotides. This class of CpGless-LacG 
construct was previously designed by Henry et al. in 1999 (Henry et al., 1999), and the in 
vivo activity in late-stage of developing mouse was not realized in wide-range of mouse 
organs until 2003 by the same group (Chevalier-Mariette et al., 2003). There, widespread 
repression of CpG-rich LacZ transgene was observed even at single copy level in all 
somatic tissues, whereas substantial expression was acquired with the CpG-less LacZ 
transgene in contrary (Chevalier-Mariette et al., 2003).  
Since we did not have any data how the transgene should function in vivo, therefore 
initially, we tried to understand the difference of X-gal staining of these two transgenic 
constructs with the help of in vitro transfected cells, embryonic fibroblast cell (3T3 cell 
line). We found that 5’UTR-LacZ transgene showed less expression than the 5’UTR-LacG 
(Fig. 2.1b). However, we created two mouse lines to understand the difference between 
their in vivo regulations. 
Importantly, when the transgenes (5-UTR-LacZ and 5’UTR-LacG) were constructed, we 
also included an important design in which both transgenes were flanked by two inverted 
terminal repeats (ITRs) from the Sleeping Beauty (SB) DNA transposon. The utility of this 
design will be described in the text below. These plasmids were injected into the pronuclei 
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of fertilized oocytes by Cyagen Biosciences. Subsequently, founder mice carrying multi-
copies of either transgene in a tandem array within a single locus were generated (Fig. 2.2).  
As explained below, the embedding of SB-ITRs in the transgene would allow us to derive 
an unlimited number of transgenic mouse lines carrying a single copy of the transgene. The 
rationale for using single-copy instead of multi-copy transgenic lines to profile L1 
promoter activity is two-fold. First, endogenous L1s, by definition, are interspersed and 
present in the mouse genome as discrete, individual copies, not in the form of tandem 
arrays. Second, it is known that tandem arrayed sequences subject to additional 
mechanisms of transcriptional regulation. This phenomenon has been previously 
documented for transgenes and referred to as “repeat-induced gene silencing (RIGS)”. 
Silencing of transgenes in animals with a high copy number is a regular feature of 
pronuclear microinjection method of animal transgenesis. Expression of large tandem 
arrays of repeated sequences may suppress the efficient transcription of transgenes (Simon 
& Knowles, 1993; Dorer & Henikoff, 1994). Indeed, our lab has observed RIGS for a 
tandem repeated L1 transgene carrying a heterologous CAG promoter (Rosser & An, 
2010). Therefore, it was essential to reduce the number of copy number of transgenes. At 
the same time, we wanted to mobilize the single-copy transgenic cassette to random loci in 
order to create unique locus-specific mouse lines. These two purposes were resolved with 
the help of the Sleeping Beauty (SB) DNA transposon system. 
 
Sleeping Beauty (SB) transposon system is a novel genetic tool that was developed around 
two decades ago (Ivics et al., 1997). It consists of two components: first, an excisable DNA 
sequence flanked by two ITRs, which are the essential sequence for the recognition and 
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mobilization by the SB transposase, the second component. Thus with the help of the latter, 
the former component is eventually excised and reinserted into other locations of the 
genome (Ivics et al., 1997). 
 
To obtain single-copy germline insertions for our transgene, the donor animal was bred 
with H1t-SB100X positive transgenic animals (Grandi et al, 2015), expressing a 
hyperactive SB transposase specifically in pachytene spermatocytes (Mates et al., 2009) 
Therefore, the excision of the transgene and their successive mobilization happened in male 
germ cells, carrying both H1t-SB100X and the L1 transgene).  
 
The progenies of this male with a wild-type female possess differential copy numbers of 
transgenes. The transgenic mice with low-copy or single-copy number were identified, 
using real-time PCR and droplet digital PCR, respectively. Next, the loci of these 
transgenes were mapped (Fig. 2.3), and primers were designed for locus-specific PCR. On 
some occasions, when the transgenes moved further due to the presence of H1t-SB100X 
in the transgene positive animals, the mobilization was detected with the help of the result 
of locus-specific PCR. In those cases of a new position, the transgene was again mapped 
(Fig. 2.4). 
X-gal staining is a fast and convenient histochemical technique to detect the expression of 
the LacZ reporter gene. The bacteria (Escherichia coli) derived LacZ gene encodes the β-
galactosidase (β-gal) enzyme. β-gal can hydrolyze different synthetic substrates. For 
example, X-gal (5-bromo-4-chloro-3-indolyl-beta- D-galactopyranoside), a synthetic 
colorless b-gal substrate. It can be enzymatically cleaved by β-gal into galactose and 5-
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bromo-4-chloro-3-hydroxyindole. The latter compound gets further oxidized into 5, 5’-
dibromo-4, 4’-dichloro-indigo, which is blue. In sum, cells expressing the LacZ reporter 
can be visualized with X-gal staining. 
In this study, the wild-type LacZ and its CpG-less derivative LacG were placed under the 
control of endogenous promoters for LINE-1, i.e. 5’UTR. The expression from them was 
marked by a dark blue stain, which was detected and quantified at the single-cell level, 
providing a robust visual readout of LINE-1 promoter activity in the main organs of 
developing mouse. 
It is already known that many mammalian tissues synthesize endogenous β-gal (GLB1 
gene product). This is a physiologically significant lysosomal enzyme that helps in the 
enzymatic degradation of glycolipids in some of the tissues. Kidney, intestine, and 
epididymis are some of these tissues, which are a particularly rich source of endogenous 
β-gals in mammals, although their presence may vary species to species (Conchie et al., 
1958; Pearson et al., 1963). 
Lysosomes have an acidic environment within it, and therefore, consistent with its 
localization lysosomal β–gal exhibits maximal activity within the range of pH 4.0 and 4.5 
but significantly lower activity at pH 6.0 or higher (Zhang et al., 1994). Importantly, 
proliferating cells have undetectable β-gal activity in situ with an X-gal staining buffer at 
pH 6.0 (Kurz et al., 2000). Yet, in senescent cells, the GLB1 gene product was reported to 
be the origin of senescence-associated β-gal activity (SA β-gal) (Lee et al., 2006). 
Therefore, if X-gal staining is found at or higher pH 6.0, it should be either originated from 
senescent cells with increased lysosomal β-gal activity or transgenic b-gal. Therefore, it is 
a technical challenge for X-gal staining to distinguish between these two types of β-gals. 
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Different modifications to the X-gal technique were previously adopted by various groups 
to increase the specificity of exogenous LacZ detection in respective experimental setups. 
These included exposing LacZ tissues to X-gal at a point below 37°C (Weber- Benarous et 
al, 1993; Sanes et al, 1986), or utilizing alternative chromogenic substrates as well as the 
fluorescent substrates of X-gal compound (Weis et al, 1991; Liu et al, 1996, Aguzzi and 
Theuring, 1994; Pearson et al., 1963; Brunet et al., 1998; Kishigami et al., 2006, Zhang et 
al., 1991). However, none of these methodologies is widely used. Here, we utilized two 
different strategies to enhance the specificity of X-gal detection.  
First, to enhance the specificity, the reporter gene, carrying a nuclear localization signal 
that results in producing nuclear-localized β-gal rather than cytosolic forms, can also be 
utilized to distinguish between endogenous and exogenous signals (Bonnerot et al., 1987). 
Therefore, in our transgenic construct, we embedded a sequence of nuclear localization 
signal as part of the coding sequence. When the cryosections of the organs were treated 
with X-gal staining solution, we observed the X-gal signals being colocalized with neutral 
red (Fig. 2.5.a), a planar phenazine dye, which found to interact with DNA (Wang et al., 
2003; Huang et al., 2001) in the nucleus. In addition to that, we validated our X-gal signals 
with immunostaining. Here, we used fluorescently labelled antibodies against lamin B, a 
protein that is anchored to the inner nuclear membrane. The antibody fluorescently marks 
the circumference of nuclei.  Indeed, the X-gal stains, blue under the visible light source, 
were found to be surrounded by lamin B signals (Fig. 2.5.b). Therefore, these results 
confirmed that the observed X-gal signals were solely derived from the transgene.  
Second, we used an optimized pH of the X-gal solution to rule the chances of detection of 
the X-gal signals out of endogenous β-gal, which, as mentioned earlier, were generally 
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active in acidic pH and inactive in high pH. To do so, we had to select an exact pH point 
from a relatively high pH gradient (7.5, 7.7 and 8.5). We observed that (Fig. 2.6) at pH 7.7, 
non-specific signals are eliminated in non-transgenic, adult mouse kidney. This condition 
also maintained substantially intense X-gal signals in the positive control Z/EG mouse. 
Z/EG (LacZ/EGFP) mouse line is a double-reporter mouse line. The reporters are driven 
by a strong CMV early enhancer/chicken beta-actin (CAG) promoter.  A LacZ gene, one 
of the reporter gene, is flanked by two loxP sequences and also followed by enhanced green 
fluorescent protein (EGFP) sequence (Fig. 2.6). Cre-mediated recombination removes the 
LacZ gene, and thus activates expression of the second reporter. Nonetheless, the CAG 
promoter maintains the expression of LacZ throughout its all developmental stages by 
default (Novak et al., 2000). In this control mouse line, the LacZ is not embedding a nuclear 
localization signal; as a result, the X-gal signals mostly come from the cytoplasm, unlike 
the reporter mouse lines generated for this study. Moreover, this signal mostly found to 
diffuse to form a smear over the surrounding cells. 
Later on, we optimized drop fixation condition also depending upon the mouse 
developmental time points to get a substantial signal intensity and a better morphology 
(Fig. 2.7 & Fig. 2.8). Multiple tissue sections from the both of major transgene lines were 
screened for quantification of the X-gal signals.  
In the LacZ line, a very small percentage of neonatal animals showed positive signals in 
no more organs than the brains (20%) and kidneys (30%) only (Fig. 2.11). The highest 
detectable signal obtained in the brain was this clearly shows that at this time point, the 
expression of LacZ transgene was silent. Therefore, not much information regarding other 
organs can be harnessed with the help of this transgene construct for this time point. 
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However, interestingly, all animals with the detectable expression values in the kidney 
belonged to one particular locus. Similarly, 2 out of 3 detectable brain values are also 
confined to another unique locus. Although the sample numbers are not large enough, still 
it might be suggesting that with taking age as a factor, expression from this transgene is 
dependent on the locus point where transgene is placed in the genome. It is also true that 
the detectable values are very rare in both brains and kidneys. The highest detectable value 
in the neonatal kidney was recorded as 6 positive cells in 10,000 cells. Upon transitioning 
to adult time point, we observed more number of organs showed detectable values outside 
the brain and kidney. At the geriatric time point (12 to 18 months old mice), X-gal stained 
cells were mostly found as shown in the scattered plot. This is a situation opposite to the 
neonatal time point. Here, rather, 20% of the brains showed detectable signals, although 
the detectable signals were of low range i.e. 0.001 - 0.04%. At this time point, besides the 
brain, kidney and testes showed a locus-dependent expression pattern with relatively higher 
detection values compared to other organs, like spleen, lung, liver and heart. The kidneys 
of the old animals showed more number of expression particularly. This might be an age-
dependent, tissue-specific change of DNA methylation (Spiers et al., 2016; Stubbs et al., 
2017). Moreover, in this case, especially, this might be due to the presence of accidental 
detection of senescence-associate beta-gal. If not in all cases, but in some cases, age-
associated glomerulosclerosis might have influenced the methylation pattern (Davies et al., 
1989; Hackbarth & Harrison, 1982). In the kidney, the positive cells had no consistent 
pattern, rather scattered throughout the cortex and medulla. In some cases in brain and 
kidney, positive cells were found to exist in the cluster, with having no positive cells in the 
vicinity. These clusters of X-gal expressing cells might have suggested clonal expansion 
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originating from a committed progenitor, of course not let alone the other possibilities. Yet, 
the X-gal positive cells lied at the border of the seminiferous tubules in testes. They are 
believed to be somatic Leydig cells or Sertoli cells, and need further confirmation. 
However, this line is not suitable for further screening. First, it had a very low range of 
detection (Fig. 2.12). For instance, the highest level of signal detected at all time point is 
less than 1 per 100 cells. Second, around 90% of animals in all time points showed no 
detectable values in heart, liver and lungs. Third, only one time point i.e. the aged mice 
showed more number of detectable signals in most of the organs Fig. 2.13. However, this 
transgenic line helped us to understand the locus dependency of expression in certain cases. 
Certainly, there is an observable difference of expression between neonatal and old-time 
points, at least in kidney and testes. This contrast of expression between these two 
developmental time points helped us to understand the notion of age-dependent expression. 
The detection values are expressed in percentage; therefore, we do believe that the low 
detections in overall is not due to difference of the sections’ surface areas in between two 
different time points. Finally, the cases where a detectable littermate of non-detectable 
animals hinted us regarding the variation due to individual expression pattern. 
However, mechanistically we tried to understand the reason behind the difference of 
expression of the LacZ and LacG construct whether it is because of the methylation of the 
promoter region. We did bisulfite sequencing to analyze the level of methylation present 
in a part of the promoter regions of the gDNA of the mice of both lines. We found that the 
promoter regions were highly methylated in both cases. More specifically, LacG had more 
methylated than the LacZ line. Despite this difference, we observed some positive cells in 
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LacG line, unlike LacZ cells (Fig. 2.29). This tells us that there might be some other reason 
involved in the silencing of the transgene, than the methylation alone.  
Therefore we had to rely on other LacG-CGless lines, with several mapped sublines, for 
the expression study. Each of these sublines has transgene placed to a unique locus point 
in the genome of the mouse. Similarly to the study with the LacZ-WT, we screened the 
tissues from mice of three different developmental time points. Unlike the LacZ line at a 
neonatal time point, where the highest detectable value in the brain was 0.0038%, the 
lowest detectable value was 0.003% for this line. Surprisingly, the highest obtained 
percentage of X-gal signal in the neonatal brain for this line was 0.6% (Fig. 2.14). Although 
it varied among the individual animals, the LacG071 line showed the highest expression 
among all the sublines present in this LacG-CGless line. In the case of heart, although we 
obtained the highest amount of expression, these signals were mostly non-nuclear 
localized. This is very unusual as because the beta-gal expressed from our transgene should 
be localized in the nuclear instead.  However, we believe these signals are from exogenous 
beta-gal, not from the counterpart, because we did not observe any expression in non-
transgenic animals. Inline to support a belief, we can put forward two pieces of evidence 
of the detection of L1 activity in a human sample. First, in a study in post-mortem human 
heart, the presence of Orf1 protein was detected highest among the non-brain samples (Sur 
et al., 2017). In another study, in an attempt of detection of full-length L1-mRNA on human 
heart muscle with northern blot assay, the relative expression was found to be 200%, which 
was again one of the highest detection in somatic samples (Belancio et al., 2010). 
Therefore, it is evidence that mammals have LINE-1 expressed in the heart. Here although, 
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the morphological entity of being expressed outside the nuclei of the cardiac cells was not 
understood well.  
Unlike the LacZ-WT line, liver and lungs showed detectable values, accounting for more 
number of organs showing up expression at the neonatal stage. The difference of the 
transgenes must be a reason why this transgene is detectable in terms of detectable positive 
signals. Testes and spleen, like LacZ-WT line, however, did not show any detectable 
values. This perhaps indicates further age-dependent silencing of the promoter in these two 
organs.  
Compared to the neonatal time point, we observed certain changes in the adult and aged 
time points (for all sublines). Firstly, in comparison to the highest of neonatal brain value 
(0.6%), the adult had a peak of ~2% and old animals had a peak of ~4% (Fig. 2.15 and 
2.16). These three values were from three different sublines. Moreover, limited sample 
number restrict us to claim a significant correlation of this upward trend with the age. High 
expression levels compared to LacZ-WT line was observed. Nevertheless, this result is 
consistent with another study on the human sample. In that study, a similar age-dependent 
L1 activity was observed by Sur et al, where they compared the ORP1p expression among 
the 15, 55, 80-year-old post-mortem human brain samples (Sur et al., 2017). They observed 
almost no expression in the sample from 15-year-old; the intermediate value was obtained 
from the 55-year old brain, and the highest value was obtained in the sample from 80 years 
old (Sur et al., 2017). Secondly, average values dropped in case of adult and geriatric lungs 
and livers from the high neonatal counterpart. However, the average values in kidneys of 
adult and aged time points did not change in comparison to that of neonatal kidneys, and 
values of spleen rose from undetectable to detectable during neonatal to adulthood, but no 
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change was observed in old animals. In the case of testes, however, a significant increase 
of values observed in transitioning from adulthood to old-time point, whereas there were 
no detectable values in case of neonatal time points. It might be due to gonadotropic 
hormones-regulated hypomethylation in testis, associated with the progression of the age 
of the rodents (Reddy et al., 1990). Apparently, similar to adult, the tissues can be 
categorized into relatively “high” (brain, heart, kidney) and “low” (spleen, lung, liver) in 
old animals.  Surely, a different organ-specific regulation, aided with the age factor, is 
observed in all lines.  
Instead of concluding the expression pattern for every line concerning age, we tried to find 
out a specific organ, which is influenced mostly by different locus positioning of the same 
transgene. To understand that, we tried to compare the highest average expression values 
from the different organs of four (commonly used) sublines of animals of three different 
time points. Notably, heart, even though having the highest expression values, were ruled 
out from the test. This is because the expression pattern of heart as discussed previously is 
not well understood. Therefore, we had to confine our test with only six organs in total. 
Therefore, among these six organs, four organs (brain, lung, kidney and testes) had the 
highest level of mean expression values. Surprisingly, kidney most frequently showed high 
expression values - at least once in all three time points of the animals belonged to all four 
lines. The notion of the frequent occurrence of the kidney might be comparable to that of 
high expressive kidneys at the old stage of LacZ-WT strain. Similar reasons should be 
echoed here. However, too little data is available on mouse kidney with a mouse-derived 
promoter for supporting our finding. However, with the help of quantitative PCR (qPCR), 
Kano et al measured the de novo retrotransposition in several adult tissues of L1RP mouse, 
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a transgenic mouse carrying L1RP element (a highly active human L1) followed by an 
enhanced green fluorescent protein (EGFP) cassette (Ostertag et al. 2000). In adult tissues 
of brain, lung, liver, kidney, and tail, they found a persistent occurrence of kidney in all the 
tissues (Kano et al., 2009). It is true that since this is a data from a human retrotransposon, 
a little can be extrapolated about the regulation of a mouse promoter activity. Therefore, it 
can be claimed here regarding our data that kidney could be a preferential place of high 
endogenous 5’-UTR promoter activity in a mouse. However, further assays might be 
helpful to establish this claim. 
It is also should be noted as this point about three outlying values which were eventually 
opted out to determine the mean value. More specifically, these all three outliers were from 
old animals, and out of three, 2 of them were in kidneys of two different mice of two 
different sublines (LacG071 and LacG061). Rest one value comes from the brain of 
different individual animal of LacG071 subline. These outliers might have caused by the 
cell-specific epigenetic dysregulation or some confounding senesce associated beta-gal 
escaped from pH control due to profound presence. Regardless of high inter-individual 
variation among the values, this test also empowered us to see the distribution of the organ-
specific quantification values. This indicated us LacG071 and LacG082 sublines as the 
most and least expressive lines, respectively. Most of the sublines screened were found to 
be less expressive, except LacG071. This together shows that there is a presence of locus-
dependent expression.  
By far, it was evident that the presence of the transgene in different locus is associate with 
differential expression of the promoter activity. Another line of evidence comes in favor of 
locus-dependent expression when we observed a drastic change was observed when 
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transgene moved from chromosome 15 (subline LacG066) to chromosome 14 (subline 
LacG221) within one generation apart (Fig. 2.19). LacG066 showed the highest amount of 
expression ever in its brain and kidney among all lines used for the collection of tissue 
sections. Unfortunately, the line of LacG066 could not be continued, but the tissues of the 
old, founder animal were collected and compared to the corresponding tissues of several 
old transgenic mice of subline LacG221. In compared to LacG066, tissues from LacG221 
line had sporadic incidences of expression for all organs. Although we have reported 
previously the incidences, where inter-individual differences of expression were present 
within an organ of an animal of particular subline and age, the ~20 fold difference in kidney 
and ~4 fold difference in the cerebellum was a strong indicator of the crosstalk between 
the promoters and the surrounding chromosomal environment. This certainly informs how 
L1 promoters function concerning location on chromosomes.  
Besides locus dependency, organ dependent promoter activity might be an obvious 
phenomenon. As we have seen that LacG071 is the subline with high promoter activity in 
terms of positive X-gal staining cells, we would like to take a closer look regarding the 
expression pattern in the organs of it in different developmental time points. In short, we 
found an organ-dependent expression differential pattern, where different organs expressed 
during different time points. These organs can be categorized into three different classes, 
namely ‘no’ expressing (spleen), ‘low’ expressing (liver, lungs), and ‘high’ expressing 
(brain, heart, kidney, and testes) (Fig. 2.20). Similar classification can be obtained from 
other LacG sublines at all points of development (Fig. 2.14 to 2.16). One of the best 
examples of organ-dependent expression was observed in spleen and testes. At the neonatal 
time point, the X-gal values in these organs were in the undetectable range. However, in 
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the two later time points, we observed them in the detectable range (Fig. 2.14 to 2.16). We 
also found that the kidney, compared to other organs, showed to as a preferential organ for 
high promoter activity (Table 2.6). Overall, it indicated that there exists an organ 
dependent promoter activity.  
We also found an age-linked promoter activity. The first evidence was the incident when 
we observe the values of neonatal spleens and testes moved from undetectable to detectable 
range in later stages of development (Fig. 2.14 to 2.16). The second evidence comes when 
we see that the brain showed a peak activity during adult time point among other points 
(Fig. 2.22). There might be different known or unknown scientific causes to address this 
observation. Here, we would like to explain this concerning the abundance of sex 
hormones. There is strong evidence that sex hormones powerfully modulate the 
neurogenesis in both males and females (reviewed in Mahmoud et al., 2016). For instances, 
long-term exposure to testosterone increased hippocampal neurogenesis in adult male 
rodents (Galea et al., 2013). Again, adult hippocampal neurogenesis was essentially found 
to be regulated with estrogens (Pawluski et al., 2009). In a rat study, adults showed the 
highest level of testosterone than the young and old rats (Ghanadian et al., 1975). This 
suggested young rodents do not have enough sex hormone present. Evidence are there that 
both sexes of rodents have drops in sex hormones are age progresses (Ghanadian et al., 
1975; Morley and Perry, 1999). It is already known also that the LINE-1 activity is a 
prominent phenomenon during neurogenesis and neuronal differentiation (Coufal et al. 
2009; Muotri et al. 2005). Taking together, we can support our data, saying that LINE-1 
promoter activity should be highest during the period of highest neurogenesis. Sex 
hormones are either not developed or its level dropped during neonatal and old-stage, 
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respectively. Therefore, these two time points most likely showed low promoter activities. 
On the contrary, whereas sex hormone level is at its peak during the adult stage showed 
high promoter activity. The values in kidneys showed the highest variations. Both neonatal 
spleen and testes did not show any promoter activity until adulthood. Unlike spleen, in the 
values of testes showed an increasing trend from the adult stage to the old stage might be 
based on the increased hypomethylation as stated earlier.   
The brain is a classic hub of retrotransposition, where LINE-1 is present in mosaic form. 
In most of the LacG sublines, except LacG071, we observed very low promoter activities 
across different brain regions. In LacG071 animal model, we also saw an approximate 
frequency of one X-gal positive neuron per 10000 of neurons. Besides, we observed an 
age-dependent change of brain region with high expression; in some cases, a sharp rise and 
fall of activity observed across different time points. For example, an elevated expression 
was found in the thalamus during neonatal age, but it shifted to the hippocampus for adult 
time point. In some animals of three time points, an expression pattern in the dentate gyrus 
was visible (Fig. 2.23). Overall, it suggested to us that there is an observable brain-region 
specific activity for our promoter, which is also age-linked. 
In adulthood, the hippocampus has been reported to be associated with the neurogenesis 
(Eriksson et al., 1998). The alterations to the hippocampal neurogenesis have been 
observed in post-mortem tissues of patients with severe depression (Boldrini et al., 2012) 
and also Alzheimer’s disease (Crews et al., 2010, Jin et al., 2004). And a higher copy 
number of LINE-1 was found in the hippocampal dentate gyrus (DG) (Coufal et al., 2009; 
Baillie et al., 2011).  Therefore, this finding in our transgenic model is relevant to the 
findings in the works of literature.  
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A mouse, an exception, with very high values (>10% positive cells) showed in several parts 
of its brain. This might be possible either by a persistent global hypo-methylation in all 
organs or due to the effect of some unknown health issue. Alternatively, this example might 
also indicate the effect of the environment on the LINE-1 promoter activity. In another 
example, during the old-time points, brain expression of hippocampus and thalamus fell 
from their peak state during adulthood.  This is quite obvious as the hippocampus is 
associated with keeping memory, and thalamus is associated with sensory integration of 
information and also with alertness. Sur et al., immune detected LINE-1 activity in the 
thalamus of a geriatric human (Sur et al., 2017). However, the existence of only two 
samples might not tell all. Overall, during the adult time point, most of the brain regions 
are elevated, and cerebellum remained with low profile among all the brain regions. Moutri 
et al., observed mobility in this region for the first time. It surprised them s this area is a 
non-neurogenic. A mobilization happening here would potentially be suggested that LINE-
1 transposition occurred in post-mitotic cells, or the cell born elsewhere but ended up 
migrating to this location (Muotri et al., 2009). Another important observation is that at the 
individual animal level for the adult animals, all brain regions tracked together, at a higher 
range or lower range (Fig. 2.22). That might suggest that level of expression is a 
characteristic at the individual level. In other words, if any mouse had high expression in a 
region of brain, high likelihood that other brain regions of the same will have high promoter 
activity too.  
Next, we tried to find out whether any specific brain region has commonly been influenced 
by the promoter activity by the different locus positioning of the same transgene. To 
understand that, we compared the highest average expression values from the different 
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brain regions of four (commonly used) sublines of animals of three different time points. 
Among these six brain regions, four regions (hindbrain, hypothalamus, thalamus and 
cerebellum) appeared with the highest level of mean expression values. Surprisingly, 
thalamus most frequently showed high expression values - at least once in all three time 
points of the animals belonged to all four lines. It is also should be noted at this point about 
two outlying values, from a particular adult animal belonged to LacZ071, were opt out to 
determine the mean values from cortex and hippocampus. These outliers might have caused 
by the cell-specific epigenetic dysregulation. Regardless of high inter-individual variation 
among the values, this test also empowered us to see the distribution of the organ-specific 
quantification values. This indicated us LacG071 and LacG082 sublines as the most and 
least expressive brain regions, respectively. This highlighted us with a clear locus-specific 
expression. And the cerebellum is the lowest expressive brain region, except in one incident 
of the brain of one old LacG061. This again indicates for a brain region-specific promoter 
activity. This might be a cell-specific incident and can be addressed with the help of single-
cell analysis. 
In this study, we would like to observe how much reproducibility the transgene is expressed 
when it is placed in the same genetic locus of the different mouse. On the other hand, we 
also wanted to know how transgene is expressed being placed into distinct regions in 
different integrant mouse lines. In the first observation, we saw that upon introducing the 
transgene in the same locus, the mice were capable of producing a more or less similar 
level of signals in littermates as well as in the progenies (for example, LacG072 line). We 




   
The eukaryotic genome has different structural variance due to insertions, duplications, 
deletions, and rearrangements. This structural variance can affect the gene expression of 
the transgene (Lydiard-Martin et al., 2014). Chromosomal localization of transgene at the 
proximity to centromere or any other heterochromatic region may contribute to the gene 
silencing. Chromosome locations which promote transgenic expression are considered as 
the transcriptionally active sites of euchromatin. The heterochromatin sites are inaccessible 
to the transcription factors and are often correlated with cytosine hypermethylation and 
also with histone hypoacetylation (Ng and Bird, 1999). As the heterochromatin integrate 
itself to the proximity of this chromatin architecture, it shows the variability of the 
transgene expression (Dobie et al. 1996; Iglesias et al. 1997). Moreover, the neighboring 
regulatory elements at the site of insertion can silence or modulate the expression of the 
transgene in mice (Hatada et al., 1999; Al-Shawi et al., 1990).  
 
It is common that different transgenic mouse same transgene exhibit different pattern of 
expression. Position effect variegation is rather a common phenomenon that is responsible 
for sectoring of gene expression patterns in both amounts and tissue specificity. It is a 
common term concerning transgene silencing in a mouse model (Dobie et al., 1997).  It is 
a position-dependent silencing of the transgene in a fraction of cells that lead to forming 
tissues, where these cells continue to inherit this trend to the daughter cells. Therefore, the 
tissue shows a variable and mosaic pattern of transgene expression. This stochastic 
silencing of the transgene is mostly caused by different mechanisms, such as chromosome 
localization of the transgene, transgene copy number, DNA methylation, aggregation of 
multiprotein complexes at the promoters with repeated sequences, etc. However, the effect 
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of variegation is difficult to detect in the tissues of the immune system and brain. This is 
because in these tissue the daughter cells happen to migrate following cell division. 
(Mentioned in Dobie et al., 1997).  
In two mice studies, the evidence of position-effect variegation was observed. First, in two 
of the 3 sublines of a transgenic mouse line, of variable positioning of the transgene (with 
beta-1actoglobulin (BLG) transgene), showed up to ten-fold inter-individual differences in 
transgenic expression within the individual mice (Dobie et al., 1996). In another example, 
in situ staining of the sections of thymus from transgenic mice carrying a human CD2 
transgene showed some clustering of transgene expressing cells (Festenstein et al., 1996). 
However, these observations point to that individual cells could able to suppress the 
transgenic expression and also can propagate the inactive state through cell division, which 
might lead to mosaic or variegated expression patterns. 
Another possibility with the silencing is the position-effect model, which is similar to PEV 
but involves the spreading of the heterochromatin region to the gene or integration of the 
locus into a heterochromatin complex in the form of loop (Wakimoto 1998). However, 
there could be many unexplained reasons for this variation in transgenic mice (Jetton et al., 
1994; Hennighausen et al., 1995). 
 
2.5.1 Overall conclusion 
This study helps us to understand many fundamental locus-specific and organ-specific 
regulation of promoter activity in vivo. However, the exact mechanism was not known very 
well. It is believed that the major factor of the differential expression is because of the 
positioning of the transgene in the chromosome (Shaw-White et al., 1993). Promoter 
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occlusion could be one of the reasons for the variability of expression due to the position 
effect.  
The striking thing that was observed here is the organ-specific regulation i.e. in some lines 
activity was low and in some lines, activity was shown to be higher, so much so we could 
categorize the organs based on the level of promoter activity. As we have observed gene 
silencing in most of the loci, we can extrapolate that the phenomena of position effect are 
a ubiquitous characteristic for the given transgene in the same genetic background.  
Age-dependent change of promoter activity was observed. For example, in spleen and 
testes, the activity was critically low in neonates but was detectable in later stages. In 
LacG071, we showed how promoter activity in the brain (Fig. 2.22) showed an 
individualized pattern as we observed in some animals. An animal showed high expression 
in one part of the brain, continued showing higher expression in other parts as well. Also, 
in rare cases, some animal showed a very high level of expression persistently in most of 
the organs. 
However, the exact factor controlling the transgenic expression was not understood. 
Therefore, further studies with transgenic mouse having a targeted placement of the 
transgene at a chose locus was necessary to observe a stable expression if any (Jasin et al., 
1996; Wallace et al., 2000). The technical caveat of this study was included, low small 
sample number, presence of high variability of the signal quantification. This expression 
pattern has relied on one type of LINE-1 promoter. 
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Chapter 3 
Specific locus- and orientation-dependent LINE-1 promoter activity 
 
3.1 Abstract  
Randomly integrated transgenes are prone to gene silencing, while targeted delivery of 
transgene to a chosen locus in the mouse genome has few advantages. Therefore, the 
transgene was targeted to Rosa26 locus, which is well known for giving higher expression 
in different animal models. To characterize the orientation-dependent expression of the 
endogenous LINE-1 promoter, we also orientated in two different directions and created 
two gene-targeted mouse lines: sense and anti-sense. We observed a thousand-fold higher 
expression in the anti-sense orientated form, unlike the sense oriented promoter. 
Expression from the sense oriented form is believed to be affected by the transcriptional 
interference from upstream Rosa promoter that might have led to read-through 
transcription that interfered with transcription initiation from the transgene promoter. No 
age-dependent difference in expression in the anti-sense line was observed, except in the 
cerebellum. In short, this orientation-dependent expression also indicated how an inversely 
placed LINE-1 insertion would be expressed in vivo in mammals. 
 
3.2 Introduction 
Gene silencing can be experienced by the introduced transgene in a random location of the 
genome of the host animal (Clark et al., 1994). Most of the mechanisms are unknown for 
this silencing, but two of the prominent reasons can be the status of the chromatin landscape 
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of the site of the host genome and the copy number of the introduced transgene (Clark et 
al., 1994; Dorer, 1997; Garrick et al., 1998). The consequences of this silencing can be 
either in mosaic expression, which might indicate a progressive silencing, or the complete 
shutdown of the transgene’s overall expression (Martin & Whitelaw, 1996). 
In this occasion, to avoid this silencing effect, a preferred chromosomal site can be chosen 
in the mouse genome (Misra & Duncan, 2002; Bronson et al., 1996). This approach can 
also give some of the added advantages. First, a favorable chromosomal site for a consistent 
expression may help to avoid the possibility of undesirable insertional mutagenesis. 
Second, the transgene can be introduced in a single copy to exclude the problems associated 
with large tandem repeats. 
One of such chromosomal locus for ubiquitous expression can be found in mouse 
chromosome 6 (Zambrowicz et al., 1997). This locus is known as Gt(ROSA)26S or Rosa26 
locus. Since the Rosa26 locus is mostly active in most of the cells or organs, any genetic 
sequence inserted into this locus must not be shut down for its expression by chromatin’s 
unfavorable configurations. Therefore, this locus position is often used to express 
endogenous sequences, and often for a reporter sequence attached with an endogenous 
promoter (Soriano, 1999; Mao et al., 2001). In addition, the promoter present on the 
Rosa26 locus can also be applied to drive a widespread expression of reporter genes in 
transgenic mice and rats (Awatramani et al., 2001). In these animal models, a ubiquitous, 
stable expression out of a single-copy transgene, being at this locus, can be utilized for 
lineage-tracing experiments in different stages of development (Soriano, 1999). 
In the earlier chapter, the expression from the transgene construct was checked by inserting 
LacG transgene in several random chromosomal sites. The neighboring regulatory 
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elements at the site of integration of this transgene might have played a vital role in 
modulating the expression (Hatada et al., 1999; Al-Shawi et al., 1990).  In this study, to 
eliminate the influence of this factor on the expression, the same transgene construct was 
inserted into the Rosa26 locus by targeted recombination, in order to test if the Rosa26 
locus would affect transgene expression (Fig. 3.1). This will help us to understand whether 
the placement of transgene at a specific chromosomal address expressed in the same 
manner in vivo or more organs.  
Notably, two ideas are important to understand at this stage as well. Firstly, it is also known 
that the position effects are influenced by the orientation of a transgene with respect to 
flanking chromatin (Feng et al., 2001). Secondly, in a human genome, in addition to sense-
oriented transcripts, antisense transcripts are produced by the anti-sense promoter present 
in the human 5’-UTR promoter, and nearly one-third of the human LINE-1s possess active 
anti-sense promoters (Speek, 2001). It might be very obvious that some of these antisense 
promoters are translated. These antisense transcripts also have regulatory roles; one of them 
is the base pair formation with the sense-oriented transcript in order to form a dsRNA 
substrate for the Dicer protein for degradation (Levin et al., 2011).  On the other hand, it is 
already known that anti-sense oriented insertion is prone to produce truncated transcripts 
with premature polyadenylation (Han et al., 2004). It is also reported that antisense 
promoters can act as an alternate promoter of the neighboring sequencing, deriving the 
formation of chimeric mRNA, which, again, interfere with the regulation of the adjacent 
genes. In humans, these anti-sense promoters have locus-dependent activities (Matlik et 
al., 2006).  In contrast, LINE-1 insertion in a sense orientation is rather rare in the protein-
coding gene in the human reference genome (Ewing and Kazazian, 2011). However, they 
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are more detrimental to a gene because RNA polymerase II strives hard to process the sense 
oriented LINE-1 insertions (Chen et al., 2006; Han and Boeke, 2004; Han et al., 2004). 
Therefore, we see that LINE-1 insertions in both orientations are dissimilar based on the 
differences of their actions and regulations. Therefore, it vital to characterize how mouse 
5’UTR LINE-1-promoter activities are expressed in sense and anti-sense being in the same 
locus to better understand the endogenous regulation of LINE-1 promoters. 
Hence, taking the above-mentioned points in the account, we systematically varied the 
orientation by letting the transgene integrate in sense and inverse orientations into the 
Rosa26 locus, and thus generated two independent mouse lines, namely sense and antisense 
lines. They will allow us to assess the effect of the construct’s orientation for the integration 
site. 
3.3 Materials and Methods 
Ethics statement 
 
The study was carried out under the strict accordance with the guidelines provided by the 
National Institutes of Health in the Guide for the Care and Use of Laboratory Animals. The 




WT and transgenic mouse lines were maintained in the C57BL/6J (B6) background.  Mice 
were housed in well-ventilated cages. In maximum, up to five adult mice per cage was 
allowed. They fed on quality-controlled standard pellet chow and pure water ad libitum in 
a regular 12-hour light/dark cycle at room temperature. Rosa26 sense and Rosa26 antisense 
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lines were produced with gene targeting (homologous recombination) method by Cyagen 
Biosciences Inc., US.  
Cryosectioning and X-gal staining of fixed tissue 
Mostly the same as Chapter 2. But the X-gal staining duration was re-optimized for Rosa26 
antisense line. 
 
Tissue harvesting and preparation 




Statistical analysis and mathematical calculations were performed using either Microsoft 
excel. Sample means were compared with the help of two-tailed unpaired T-test used and 
expressed in terms of the p-value. Analysis of replication consistency was tested with 
Coefficient of variation (CV%) was used to analyze replicate consistency. Any CV values 
with <100% were regarded as with a lesser variation. 
 
Genotyping PCR 
Genotyping of the mice was performed with gDNA mainly from their tail biopsies. A PCR 
reaction using ExTaq or ExTaq HS polymerase was run for the detection of the presence 









   
Line  Primer pairs Expected band PCR protocol 






WA567& WA568 398 bp (WT 
band) 






C min/s  
94 3min  
94 30  
62 35 33cyl 
72 35  


















Table 3.1 Genotyping protocols for two transgenic mouse lines. 
 
Microscopy and image analysis 
Same as Chapter 2 
 
QuPath 
Same as Chapter 2 
 
QuPath Data Plot 




3.4.1 Unlike Rosa26 sense line, Rosa26 antisense tissues needed further optimization 
due to high abundance of the signals 
 
At the outset, the same X-gal staining protocol as mentioned for the genotypes in Chapter 
2 was adopted.  However, excessive staining was obtained for the anti-sense line. 
Therefore, to restrict the excessive staining, which might interfere with the quantification 
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of the signals, we had to reoptimize the staining time for Rosa26 antisense animals only, 
depending on the age of the animals. For adult tissues, time was reduced to 45 minutes for 
brain sections (Fig. 3.2.1a) and 120 minutes for other tissues (Fig. 3.2.1b) using a standard 
concentration of X-gal (25mg/ml). For neonatal tissues, the optimal staining of all tissues 
was obtained with a lower concentration of the X-gal compound (6.25mg/ml) for 4 hours 
(Fig. 3.2.2). Figure 3.3 shows the typical staining patterns of these two lines in the 
hypothalamus of neonatal mice.  
 
Figure 3.1. Two different orientations of the promoter targeted into the Rosa26 locus. 
 
1. Adult tissues of Rosa26 anti-sense line 
(a) Brain (Cerebellum)  
45 mins incubation with X-gal 25mg/ml 
 
Saha042 






   
(b) Kidney 
120 mins incubation with X-gal 25mg/ml 
 
Saha042 




2. Neonatal tissues of Rosa26 anti-sense line 
Brain (Thalamus)  
4 hours incubation with X-gal 25mg/ml 
 
Saha088 
Overnight incubation with X-gal 25mg/ml 
 
Saha088 
Figure 3.2: Optimization of staining condition for Rosa26 antisense line. 1. Adult time 
point in brain and kidney 2. Neonatal time point in the brain. 
 
 
Rosa26 sense (S030), Brain (Thalamus) 
 
 Rosa26 sense (S063), Brain (Thalamus) 
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Figure 3.3: Desired staining patterns matched with their corresponding the two 
genotypes used in this study. 
 
3.4.2 Promoter orientation altered the level of expression: Rosa26 antisense had 
1000 fold more expression than the Rosa26 sense line 
 
In the Rosa26 antisense line, a high X-gal expression was observed in all organs. 
Approximately, more than 10% of cells in all organs showed to possess positive staining. 
However, exceptionally, in few cases in lungs and spleen had low expression. In the heart, 
similar to the random lines, non-nuclear localized positive signals were observed. 
In this Rosa26 sense line, most of the expressions are undetectable. However, a few 
detectable positive signals have been identified in brain and kidney of neonatal time points. 
Similar to the neonatal situation, at the adult stage, detectable signals were identified in the 
brain, lungs, and testis. Although, the organ with the highest detectable positive signals 
was carrying a significantly low percentage of positive cells (less than 0.1%). In both of 
the lines, approximately, there is a 1000 fold difference in the level of expression between 
Rosa26AS and Rosa26S. The expression (Fig. 3.4) was compared between two different 
time points i.e. the neonates and adults of Rosa26AS and Rosa26S lines. 
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a.  
b.  
Figure 3.4 The difference of expression of two gene-targeted lines at two different 
time points. (a) The orientation-dependent difference of expression, (b) age-dependent 











   
Sample images:  
(a) Antisense line 






(b) Sense line 
 
           





Saha156 (brain) Saha156 (kidney) 





   
  
  
Figure 3.5 Sample images from Rosa26 anti-sense (a) and sense lines (b). (Note: 
some regions are zoomed in to show the contrast/pervasiveness of the expression). 
 
3.4.3 There is developmental time-dependent brain expression in brain regions of 
Rosa26 antisense line 
In the Rosa26 anti-sense line, for both of the time points, expressions were very high 
(Fig. 3.6). In an average, ~13.35% cells are X-gal positive at neonatal time point. 
Among these values, the thalamus has the leading expression. In neonatal time point, 
unlike others, the cerebellum has statistically significant (p value= 0.037968) 
difference between both time points of neonatal and adult within the given set of sample 
number. On the other hand, in the adult time point, the number of positive cells 
decreased to less than 10% averagely (6.65%). At the same time, the thalamus values 
specifically fell to approximately 1% (0.68%). 
In Rosa26 sense line, most of the signals are undetectable (Fig. 3.6). At the neonatal 









   
went undetectable in case of the adult time point. The hindbrain showed detectable 
range in both neonatal as well as in adult time points. 
 
Figure 3.6 The orientation-dependent expression differences of the transgene at two 
developmental time points. 
 
3.4.4 Transgene in Mov10L1 knock out mouse background did not show over-
expression of promoter activity in testis of Rosa26 sense line 
 
To look for whether the hypermethylated transgene promoter can over-express promoter 
activity in the hypomethylated background. We observed that sense-line in Mov10L1 KO 
background did not produce and signal. Only a few basal cells in the seminiferous tubules 
expressed promoter activity. 
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To rule out the influence of integration site and variable copy number on the expression 
pattern of the transgene, we knocked it in single copy into a specific locus, Rosa26. At the 
outset, we had two choices of favorable chromatin loci for ubiquitous and stable 
expression, namely HPRT locus and Rosa26 locus. As the HPRT locus is located on the X 
chromosome, the expression is subject to random X-inactivation, or in other words, the 
expression would be guaranteed only in case of homozygous females. Moreover, the 
evidence is there that even in that case too, expression in certain tissues, like kidney and 
liver, are low and sometimes undetectable (Bronson et al., 1996; Hatada et al., 1999). 
Therefore we had to opt for the alternative choice i.e. Rosa26 locus. This has been widely 
used for favorable gene targeting site in mouse (Friedrich & Soriano, 1991; Srinivas et al., 
2001; Nyabi et al., 2009).  In addition to the use in mouse, this chromosomal site has also 
been used for traditional homologous recombination in humans and rats (Irion et al., 2007; 
Kobayashi et al., 2012). This also suggested that this site has limited inter-species 
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variability for stable expression. This ubiquitous expression also suggested that the 
transcriptional activity is less likely influenced by the chromatin configurations, which 
sometimes offer transcriptional repression through several regulatory elements in the 
flanking chromatin landscape. Whatsoever, we targeted our LacG transgene into this locus 
for a reliable expression pattern. 
Similar to as described in Chapter 2, we stained the fixed tissues with X-gal from the mouse 
at two time points: neonatal and adult. At first, we attempted to keep the X-gal staining 
time same for the random lines and these two targeted lines. Upon staining the tissue for 
regular length of time, we observed a dark, heavy, diffusible stains only in the anti-sense 
line. It was unrealized until then that the blue compound as a product of the enzymatic 
reaction is, however, diffusible in fixed tissue and could eventually blur the distinctions 
between the nuclear and cytoplasmic signals (Sanes et al., 1986; Gray et al., 1988; Weis et 
al., 1991). Overall, this the problem became apparent when we stained the samples from 
the Rosa26 antisense line with the optimized X-gal staining condition used in Chapter 
2.  The heavy blue stains darkened the sections, and almost completely masked the neutral 
red co-stains. Co-localization of both of the signals, where applicable, was needed to 
determine the total fraction of transgenic positive cells within the whole population of cells, 
which was determined by the total number of neutral red-stained cells. Therefore, 
strategically, we had to shorten the duration of X-gal staining for the Rosa26AS genotype 
so that we have distinct nuclear-localized signals to represent the total number of transgene 
positive cells. 
In the revised protocol, we still observed a pervasive X-gal staining in most of the organs 
of heterozygous antisense animals, whereas we found almost no staining in the 
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cryosections of sense line. An estimation of the difference was 1000 fold between these 
two lines. Notably, the highest value of signal quantification if the Rosa26 sense line is 
0.1%, whereas the estimated average signal quantification of Rosa26 sense line was around 
10%. This is the novel approach where endogenous LINE-1 promoter was ever targeted 
into Rosa26 locus. Therefore, no data related with this transgene construct being targeted 
in this specific locus or other related loci was available to understand the mechanisms of 
silencing of the Rosa26 sense oriented promoter and the same of heavy staining of the anti-
sense oriented promoter.  
However, a similar study was performed using the same reporter in HPRT locus by Stringer 
and colleagues (Shaw-White et al., 1993). There they observed a similar contrast between 
two orientations of LacZ transgene targeted into the HPRT locus. In that study, they 
targeted a LacZ gene, under control of an SV40 promoter, to the HPRT locus in ES cells. 
The expectation was that, since HPRT is a 'housekeeping gene' and is expressed 
constitutively in all cell types, LacZ would be ubiquitously expressed. The targeted ES 
cells, all of which expressed LacZ in culture, were injected subcutaneously into syngeneic 
strain 129 mice and allowed to grow into tumors containing multiple differentiated tissue 
types, which were then stained for beta-gal galactosidase activity. Targeted cell lines with 
LacZ in inverse orientation to the direction of HPRT gene transcription expressed high 
levels of beta-galactosidase in epithelial cells. However, targeted cell lines containing a 
transgene oriented in the same direction as the HPRT gene transcription did not express 
high levels of LacZ in any differentiated cell type. Analysis of transcripts suggested that 
this orientation effect may have been the result of transcriptional interference perpetrated 
by the HPRT gene promoter. Cell lines in which LacZ was oriented .in the same direction 
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as HPRT contained RNA transcripts that appeared to originate from the HPRT promoter 
and proceed through the transgene’s promoter and the LacZ coding region.  These RNAs 
would not be expected to be capable of producing an HPRT-beta-galactosidase fusion 
protein because of the presence of a stop codon in between the HPRT open reaching frame 
(ORF) and the beta-galactosidase ORF. Some direct-orientation cell lines contained no 
detectable 3.3 kb transcript. It might be possible that the low abundance of the 3.3 kb 
transcript in these cell lines was due to read-through transcription interfering with 
transcription initiation from the transgene promoter (Shaw-White et al., 1993). Notably, 
inconsistent with their result, in our result too, the quantified expression values from the 
sense line is lowest in compared to the randomly integrated lines (with intermediate values) 
and antisense line (with highest) values of expression. 
In In this present study, we also predict that similar mechanisms of transcriptional 
interference might have taken place, completely ruling out the trivial possibility that the 
plasmid was constitutively defective for expression of beta-galactosidase because 3T3 cells 
transfected with this DNA were positive in the X-Gal assay. Overall, this might be the 
reason for how around 10% of all organs showed positive staining in the antisense line. 
Unstained cells in the organs of Rosa26 antisense, along with the lowly expressed organs, 
like lungs and spleen, might have different cell-specific or organ-specific regulations which 
restricted the transgene expression. These types of regulation can be due to tissue-specific 
and developmental stage-specific transcription factors, like auxiliary proteins and DNA-
binding sequence-specific transcription factors or host epigenetic factors. Any of this kind 
of mechanism either have gone loosen or restricted at the cellular or organ levels mouse of 
either of the developmental time points. Matlik et al., showed that there are a locus-
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dependent and tissue-specific expression pattern of antisense promoter’s activity in human 
in vivo. There, they have demonstrated that LINE-1 ASP antisense promoter (ASP) is 
active in a wide variety of normal human tissues, but L INE-1 ASPs at defined loci are not 
active in all tissues (Matlik et al., 2006).  There they explained that varies based on minimal 
sequence divergence and differences in their epigenetic state. In this case, we explain our 
case with the latter phenomenon as the probability of the former case is null. 
  
It is also possible that the lack of expression in these cells could have been due to a silencer-
effect exerted by the 5'-end of the Rosa26 segment juxtaposed to the transgene gene. 
However, the activity of such a hypothetical cis-acting a silencer would be necessarily 
conditional in two ways. Firstly, it would be inactive in cells in which LacZ expression 
was observed. Secondly, it would be inactive when located downstream of the transgene. 
In heart, we have not found any nuclear-localized signals like that we saw in chapter 2. 
However, we believe that these are real signals as we did not obtain any signals in transgene 
negative animals, but we cannot give any explanation to the cause of these signals of this 
shape. 
Since we see the brain is an important site with adequate expression in random lines, we 
took a closer look at the brain in Rosa26 antisense and sense lines. In Rosa26AS, overall 
we observed a consistent high expression in both of the developmental time periods. 
However, compared to the neonatal time point, we observed a region-specific fall of 
expression, particularly in the thalamus at adult time point. This observation is just opposite 
to what we observed in the highly expressed line, LacG071, of random lines. However, it 
is difficult to conclude on this due to the small sample number. Here, we also observed an 
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overall fall in the total number of X-gal positive signals from neonatal time point to 
adulthood. This might be due to age-dependent phenomena combined with the intrinsic 
characteristic of this locus for this promoter. However, among all regions, the only age-
dependent difference in expression in the cerebellum was showed significant statistically 
in the given set of data (however, this significance might not be staying upon increasing 
the sample numbers).  This might tell us that some other factors might be involved in case 
of regulation of transgene in inverse orientation, which might determine which cells have 
high levels of beta-galactosidase, and which cells do not. As we know that different regions 
of the brain nurture more or less particular types of brain cells, and with the progression of 
age, these type of cells either differentiate into other types or degenerate. Therefore, this 
age-dependent the difference in expression in cerebellum might hint us regarding a cell 
type-specific expression, and also expression variegation, where expression of beta-
galactosidase varied within a population of cells of one type. In the next chapter, we will 
show how we attempted to differentiate these cell types which particularly held an 
expression of the antisense-oriented transgene. On the contrary, as like most of the organs 
in the Rosa26S line, brain regions in the same line are mostly silent. Any occasion of 
expression in certain regions can be called as a rare cell-specific incident and could be 
explained appropriately by analyses at the single-cell level. 
Human LINE-1 promoters are bidirectional, containing a sense promoter responsible for 
transcription within the LINE-1  element and an antisense promoter (LINE-1 -ASP) that 
can drive transcription of adjacent regions giving rise to transcripts composed partly of 
LINE-1 and partly of genomic sequence (LINE-1 chimeric transcripts (LCTs) (Speek, 
2001; Cruickshanks & Tufarelli, 2009).  Recent evidence suggests the existence of a causal 
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link between aberrant activation of individual LINE-1-ASP promoters and cancer 
development and progression (Weber et al., 2010; Wolff et al., 2010). 
Our result highlighted that anti-sense promoter activity is thousand fold higher in compared 
to sense orientation being positioned in a permissive locus, like Rosa26. In type of cases, 
more active promoters (in this case Rosa26 promoter), in the upstream, may act as an 
alternate promoter to form a read-through transcript and ultimately leading to suppression 
of the sense oriented LINE-1 promoter to form transcript from ORF1 & 2 sequences. On 
the other hand, the anti-sense promoter can be unaffected. Overall, this reflected how the 
sense and antisense promoters, being inserted into a permissive locus may behave. 
A probability of a certain level of methylation-dependent gene repression is always there, 
regardless of the chromosome position. In case of any hypomethylation-induced activation 
of LINE-1-ASP promoters can further drive the transcription of cancer-specific LINE-1 
chimeric transcripts (LCTs) transcribed in the same (sense) or opposite (antisense) 
orientation with respect to the neighboring genes (Cruickshanks & Tufarelli, 2009). In 
another instance, it is evidenced by weber et al. that demethylation of a LINE-1 antisense 
promoter in the cMet locus impaired Met signaling through induction of illegitimate 
transcription (Weber et al., 2010). Although the methylation of the promoters was not 
checked, yet it is believed that on being hypomethylated this antisense LINE-1-prompter 
can bring a synergistic effect in terms of intense transgenic expression. Knocking out the 
piRNA-DNA methylation pathway leads to DNA methylation at LINE-1 Promoters and 
thus it led to 70-fold increase in retrotransposition in postnatal germ-cell development in 
mouse with a 5′UTR-ORFeus transgene (Yang & Wang, 2016; Newkirk et al., 2017). 
Therefore, we bred a piRNA KO (Mov10l1−/−) mouse with LacG oriented in sense line. 
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Although we could observe a spermatogenic failure in the germ-lines. However, we could 
not see any increased expression of promoter activity (Fig. 3.7). This might indicate that 
prevalent RNA interference, but not the demethylation is responsible for the lower number 
of positive cells. 
Overall, we found that there is an orientation-dependent expression of our transgene 
construct being targeted into the Rosa26 line. This finding is consistent to an earlier 
observation, however, in cell lines, where CMV the driven expression of the reverse 
tetracycline transactivator (rtTA) at the Gt(ROSA)26Sor locus was inferred to be more 
robustly expressed in the antisense orientation (Strathdee et al., 2006). Besides showing an 
interesting expression of our transgene in Rosa26 antisense orientation, the non-expression 
from the sense orientation at the same time, also, reminded one of the limitations of gene 
targeting in Rosa26 locus i.e. transcriptional interference from upstream promoter 
sequences (which can be limited by the use of an insulator element). Other limitations of 
the general application of this method with respect to exogenous promoters have essentially 
limited by the transcriptional complexity of the Rosa26 locus (Zambrowicz et al., 1997) 
and of course a lack of systematic studies. 
3.6 Conclusion 
To rule out the effect of the flanking chromosome site on the transgene expression, we 
were able to gene target our LacG transgene in two orientations into a specific locus, 
Rosa26, which is well known for a ubiquitous expression in different transgenic animals. 
In this case, we were able to show that the same transgene show contrasting orientation-
dependent expression pattern in two lines. This again proves that the surrounding 
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chromosomal landscape was a prominent determining factor why promoter activity is 
repressed in randomly integrated lines and also provides the necessary evidence that 
endogenous LINE-1 promoter in anti-sense orientation might have a profound expression 
in the mammalian genome. 
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Chapter 4 
Cell-specific LINE-1 Promoter Activity 
 
4.1 Abstract 
The mammalian brain is composed of different types of cells, which can be classified based 
on their functions. Previous chapters showed brain-region specific promoter activities. This 
possibly indicated a physiological role of the LINE-1 activity in the mammalian brain. It 
is assumed that identification of the cell types, carrying the promoter activity would be 
helpful to reveal the role of LINE-1 on neurophysiology. Therefore, this chapter aimed to 
identify the major brain cells that hold the promoter activity in terms of transgene 
expression. In this study, six different brain cell-markers were used to detect several 
neuronal, macroglial, microglial, and stem cell types. A fluorogenic substrate was used to 
replace the X-gal compound for detecting the promoter activities. At the same time, an 
automated, quantitative signal detection approach was also implemented for the detection 
of the percentage of brain cell types holding the promoter activity in a specific brain region. 
Although all the brain markers were successfully detected, yet a contradictory background 
problem due to the use of fluorogenic substrate halted the progress. An alternative approach 




It has been a while that we are aware that retrotransposition activity presents a formidable 
threat to the host genome. They are involved in causing several heritable and inheritable 
diseases in mammals, including humans (reviewed in Saha & An, 2019).  
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A systematic spatial and temporal control of gene expression is an essential part of 
biological processes, like proliferation, apoptosis, development, differentiation and aging. 
In a different type of cells, these regulations are specifically maintained by a class of gene 
regulatory elements, known as enhancers. These enhancers are a short sequence of 
approximately 1 kb long located either upstream, downstream or inter-introns, can harbor 
specific transcription factors to produce a cell-specific expression pattern (Levine, 2010; 
De Laat and Duboule, 2013). Despite our advanced knowledge in the retrotransposon field, 
our understanding is still extremely limited on how LINE-1 activity is determined by these 
type of cell-specific regulations – and at least, which cell types promote or suppress 
retrotransposition activity.  
So far, we established that individual LINE-1 promoters exhibit both loci- and tissue-
specific activation, which is also orientation dependent. This implied that LINE-1 promoter 
activity originates from some permissive loci and also suggesting that a new layer of cell-
type-specific regulation that controls endogenous retrotransposons.  
Over the past years, LINE-1–EGFP reporter system had been successfully utilized in 
animal models to elucidate the effect of LINE-1 mobilization in age-dependent 
neurogenesis, suggesting the brain as a hotspot for LINE-1 mosaicism (Coufal et al., 2005; 
Muotri et al., 2005; Garcia-Perez et al., 2010). Our studies in the past two chapters showed 
a substantial expression at the brain level, and interestingly in specific brain regions. These 
prompted us to translate our approach to determine the brain cells specific to hold the 
promoter activity. Therefore, in the present study, we tried to determine which brain cell 
types mostly held the LINE-1 promoter activity is mostly expressed random line and other 
two different gene-targeted lines.  
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4.3 Materials and Methods 
Ethics statement 
  
The study was carried out under the strict accordance with the guidelines provided by 
National Institutes of Health in the Guide for the Care and Use of Laboratory Animals. The 




Same as Chapter 2 
  
Tissue harvesting and preparation 
Same as Chapter 2 
  
Cryosectioning  
Same as Chapter 2 
Note: Tissues were sectioned in a thickness of 14um for immunostaining. 
Immuno-staining followed by containing Res-gal staining with secondary antibody 
  
Brain sections were obtained in 14um thickness. Immersed in 1XPBS for 10 minutes. 
Rinsed with water briefly. Incubated at RT with 1xPBS with only 0.3% TritonX100 for 5 
minutes 3 times. Blocked for 2 hours at RT with a blocking buffer, containing 0.3% Triton 
X100 in 1XBPS and appropriate serum. Except the case of using anti-mouse primary 
antibody (used 1% BSA), blocking buffer in all other cases was containing 5% donkey 
serum. Overnight incubated with a blocking buffer with a required ratio of primary 
antibodies. Incubated at RT with 1xPBS with only 0.3% Triton X100 for 5 minutes for 3 
times. The secondary antibody in appropriate conc., containing 1mM Res-gal for samples 
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of Rosa26 antisense line and 2mM for the samples of random lines, was used to incubate 
at 37C for 1 hour. Incubated at RT with 1xPBS with only 0.3% TritonX100 for 5 minutes 
for 3 times. Incubated for 5minutes with DAPI. Incubated at RT with 1xPBS with only 
0.3% TritonX100 for 5 minutes 3 times. Rinse with water. Mounted with 1%PVA before 
putting on coverslips. Note for the procedure to prepare 2nd dilution: Prepared 1M Res-gal 
stock in DMSO. The appropriate volume of Res-gal was added to a solution, containing 
10M MgCl2 and 0.3% of TritonX100 in 1XPBS. Vortexed vigorously for 2 minutes. 
Centrifuge for 1 minute at 14000 rpm. Pipette out the supernatant and add the appropriate 
volume of a secondary antibody. Did all steps in the dark as Res-gal is light-sensitive. 
 
Chemical/ Reagents Manufacturer Specification 
 
Res-gal (Resorufin Beta-D-
galactopyranoside) MW 375.33 
 
 






Mouse anti-GFAP (1:1000) Sigma  Ref: G3893 
Lot: 056M4864V 
Rabbit Anti-NG2 (1:500) Millipore Ref: Ab5320 
Lot: 251778 
Goat Anti Sox2 (1:100) Santa Cruz  Ref: SC-17320 
Rabbit Olig-2 (1:1000) Millipore Ref: AB9610 
Lot: 2728398 
Rabbit Anti-NeuN (1:1000) Abcam  Ref: AB177487 




Donkey Anti-goat Alexa fluor 488 
(1:1000) 
Jackson Lab  Ref: A-705- 645 147 
Donkey Anti-rabbit Alexa fluor- 488 
(1:500) 
Invitrogen A21206 Lot: 2045215 
Donkey Anti-mouse Alexa fluor-
488 
(1:1000) 
Invitrogen A21202 Lot: 1305303 
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Donkey Anti-rabbit Alexa Fluor 594 
(1:500) 
Invitrogen A21207 Lot: 567297 
4′,6-diamidino-2-phenylindole 
(DAPI) (1:1000) 
Thermo Scientific Ref.: 62248 
 
Other reagents 
Bovine serum albumin (heat-shock 
treated) 
Fisher Bioreagents CAS 9048-46-8 




Dimethyl Sulfoxide (DMSO) VWR Life Sciences CAS 67-68-5 
Lot: 19C2656019 




The confocal microscopy of the immunostained microscopic slides was taken with the help 
of Olympus FV1200 Scanning Confocal Microscope (x20 dry) based at the Functional 
genomics core facility at South Dakota State University. The images were analyzed by a 
software Fluoview Fv1000. Samples were excited at 488 nm (Alexa Fluor 488), 405 nm 
(DAPI), 568 nm (Res-gal) and the emission light was collected at 520 nm, 461 nm, and 
559 nm for each of these channels, respectively. Z-stack images of approximately 4 μm 
thickness were taken for each sample at 3 μm step sizes. Each frame consisted of a 1024 × 
1024 pixel image, captured at a rate of 20 μs/pixel. 
The confocal images were further analyzed with the help of image J software (version 
1.52p). In total, nine stacks from each of the three channels (with 3 stacks per channel) 
were stacked individually after adjusting for the parameters, like brightness and Z 
projection (type: “Max intensity”). Later, the three stacked images for each channel were 
merged and was saved as .tiff file. This image was fed in QuPath for the quantification of 
cells with signals. 
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QuPath: quantification of signals 
Two image types in the program QuPath were used for quantification: brightfield (H-DAB) 
for X-gal stained tissues and fluorescence for immunofluorescence tissues. For the X-gal 
stained tissues, a different script was created for each tissue based on its specific 
characteristics. Each script was modified using a certain number of channels. Each channel 
denoted a specific command to either denote a cell as either positive, negative, or border 
based on the intensity of the hematoxylin or DAB. The mean, sum, and max intensity of 
these two parameters were optimized over a range of several tissues to accurately detect an 
X-gal positive cell from a negative. A percentage was then derived by taking the number 
of positive cells divided by the number of negative cells plus positive cells and then 
multiplied by 100. The cells detected as border were determined to be falsely detected cells 
and were not included in this equation. Immunofluorescence followed this same protocol, 
but channels were focused on FITC, DAPI, and Res-gal instead of hematoxylin and DAB. 
4.4 Results 
In this experiment, we attempted to co-stain five brain cell markers (NeuN, Olig2, NG2, 
GFAP & Sox-2), along with Res-gal and DAPI on the same section on the same tissue 
section. These tissue sections were from animals of random lines as well as Rosa antisense 
lines. N804 is an animal belonging to the highest expressing LacG071 line, and Saha063 
and Saha100 are the animals that belonged to Rosa26 antisense lines. 
Figures 4.1 to 4.5 showed how well the neural markers could detect the actual cell type in 
the presence of Res-gal and DAPI. Figure 4.6 shows the detection of microglial marker 
(IBA-1) with the help of immunostaining. This case is, however, free from Res-gal. 
151 
 
   
Next, we wanted to detect these three signals with the help of QuPath. And we could 
successfully code a script which perfectly detected different signals, belonged to different 
channels (RGB) (Fig. 4.7a). Figure 4.7b shows the concept for the quantification of co-
localizing signals. Here only those cells colocalizing three colors are expressed in 
percentage value. 
Figure 4.8 shows all types of colocalizing detections detection was necessarily containing 
DAPI signals in it. Here, different color codes are used to mark different types of 
detections. 
Figure 4.9 (a) and figure 1.9 (b) shows the total percentage of cells showing colocalization 
of three signals at once for NeuN and Sox-2 markers, respectively. 
A sample contrast between two thalamic regions of two different lines (Fig. 4.10), Rosa26 
antisense line and LacG071 line. It represented almost a similar number of cells stained 
with Res-gal. It also indicated that all the Res-gal signals were nuclear-localized. 
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Figure 4.1. Detection of the GFAP expressing astrocytes (green) in the hippocampus (a) 
and hypothalamus (b) of the brain of animals belonging to LacG071 line and the Rosa 26 
antisense lines, respectively. In these confocal images, Res-gal fluorescence (red) was 
found to be co-localized in the DAPI stained nuclei (blue) cells. 
GFAP             
a. N804 (hippocampus) 
 20X 
b. Saha100 (hypothalamus) 
 40X 
Color codes: Green = GFAP cells ; Blue = Dapi;  Red= Resgal         
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Figure 4.2: Detection of the Olig-2 expressing oligodendrocytes (green) in the thalamus 
(a) and brain stem (b) of the brain of animals belonging to LacG071 line and the Rosa 26 
antisense lines, respectively. In these confocal images, Res-gal fluorescence (red) was 
found to be co-localized in the DAPI stained nuclei (blue) cells. 
Olig-2           
A. N804 (Thalamus)                                                                 
 20X 
b. Saha100 (Brain stem)                                                                       
 20X 
Color codes: Green = Olig-2 cells ; Blue = Dapi;  Red= Resgal 
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Figure 4.3. Detection of the NeuN expressing neurons (green) in the thalamus (a) and 
brain cortex (b) of the brain of animals belonging to LacG071 line and the Rosa 26 
antisense lines, respectively. In these confocal images, Res-gal fluorescence (red) was 
found to be co-localized in the DAPI stained nuclei (blue) cells. 
NeuN          
a. N804 (Thalamus)                                                            
 20X 
b. Saha063 (Cortex)                                                                            
 20X 
Color codes:  Green = NeuN cells ; Blue = Dapi;  Red= Resgal 
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Figure 4.4. Detection of the Sox-2 expressing stem cells (green) in the subventricular 
zone (a) and subgranular zone (b) of the brain of animals belonging to LacG071 line and 
the Rosa 26 antisense lines, respectively. In these confocal images, Res-gal fluorescence 
(red) was found to be co-localized in the DAPI stained nuclei (blue) cells. 
Sox2               
a. N804 (Subventricular zone)                                                      
 20X 
b. Saha100 (Subgranular zone)                                                        
 20X 
Color codes:   Green = Sox-2 cells; Blue = Dapi;  Red= Resgal 
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Figure 4.5. Detection of the NG2 expressing oligodendrocyte progenitor cells (green) in 
the hypothalamus (a) and subgranular zone (b) of the brain of animals belonging to 
LacG071 line and the Rosa 26 antisense lines, respectively. In these confocal images, 
Res-gal fluorescence (red) was found to be co-localized in the DAPI stained nuclei (blue) 
cells. 
NG2                   
a. N804 (hypothalamus)                                                                                        
 20X 
b. Saha100 (Subgranular zone)                                                        
 20X 
Color codes:    Green = NG2 cells; Blue = Dapi;  Red= Resgal 
157 
 
   
Anti IBA-1 detection 
 
Primary antibody: Rabbit Anti-IBA-1  
Secondary antibody: Donkey anti-rabbit Alexa F594  
Blue = Dapi;  Red= IBA-1 
Figure 4.6. Detection of the IBA-1 expressing microglial cells (red) in the hypothalamus 
of the brain of the animal, Saha100, belonging to the Rosa 26 antisense lines. DAPI 









   
b. Venn diagram conceptualizing the calculation  
 
Figure 4.7. QuPath detection. (a) A real-time detection of immunofluorescence signals 
& (b) Venn diagram conceptualizing the calculation of the percentage of transgene 
expressing brain cell markers.  The calculation was made using a mathematical formula 
mentioned in the inset (where, F= number of cells expressing cell markers, D = DAPI 
stained nuclei, & R= Res-gal stained cells). 
 
a. All channels b. Only DAPI detection c. Only red detection 
   
 
d. Only cell marker 
(green) detection 










   
Figure 4.8. Effectiveness of QuPath enforced detection. Here, different detections 
denoted with multiple colors (a) have been segregated into specific condition combining 
individual colors (b-e). 
 
a. Brain maker (NeuN) 
 
b.  Sox 2 marker 
 
Figure 4.9. Percentage of Res-gal positive cells in different parts of mouse brains 






   
a. Thalamus of N804  
  
Resgal signals alone Resgal colocalized with DAPI 
 
b. Thalamus of Saha100 
 
  
Resgal signals alone Resgal colocalized with DAPI 
Figure 4.10. The difference in Res-gal signals between two thalamic regions of two 







   
4.5 Discussion 
The primary idea of this chapter was to detect the transgene positive brain markers. Due to 
the presence of the LacG reporter cassette in our transgene, our transgene, if translated will 
translate into the beta-galactosidase enzyme, which can enzymatically break down many 
chromogenic and fluorogenic substrate. Resorufin β-D-galactopyranoside (or, Res-gal) is 
a fluorogenic substrate, which when breaks down form a fluorescence emitting substance. 
Here, we wanted to replace X-gal with this compound since both of them share the same 
mechanism for detection. Moreover, when we use it in conjunction with DAPI and a 
secondary antibody with a fluorophore attached to it. In a successful detection of primary 
antibody, we shall get the overall result in a fluorescent form, again provided that transgene 
is expressed and the product degrades the Res-gal.  
For the in situ detection of the cells, samples from two different mouse line were chosen, 
especially those which shows promoter activity in terms of X-gal signals. Such mouse lines 
are Rosa26 line and mot expressing LacG071 subline. We optimized an immunostaining 
protocol to use the Res-gal, which we had to incorporate in the final step of incubation with 
a secondary antibody.  
We chose five different common brain markers for detection with the primary antibody. 
They include the neuronal marker (NeuN), glial markers (NG2, Olig2, and GFAP), and 
stem cell marker (Sox-2). All could be detected successfully, and their phenotypes were 
verified with the help of experts. With a similar protocol, we could also successfully detect 




   
As expected, we obtained the Res-gal signals colocalizing in the nuclear mostly. Therefore, 
we wanted to detect the percentage of cells that are at the same time detected by cell 
markers and express Res-gal. These classes of cells are, in other words, transgene 
expressing specific brain cells.  
And we took the help of a pathological quantifying software, QuPath to detect the 
fluorescence signals separately and effectively. We made generated the script in such a 
way that DAPI signal as essential criteria to be present for each of the co-localization and 
ruled out any combination not having DAPI signal excluded.   
The images were taken in confocal microscopy from different brain regions. After image 
processing, we quantified the percentage of cells in each of the brain regions. The results 
of the analyses (Fig. 4.9 a & b) indicated a background problem for the Res-gal. It meant 
although the Res-gal signals were nuclear-bound, yet we observed the same abundance of 
signals in both of these mouse lines (Fig. 4.10). However, the X-gal data did not turn in 
with such a result. Therefore, it was concluded that though X-gal and Res-gal share similar 
degradation pathways by beta-galactosidase, there is a major difference in their sensitivity.  
It was possible that these substrates got broke down within a short period and had enough 
time to diffuse some other parts of the same section while being incubated. 
Therefore, this technique can be optimized further with different duration of incubation or 
by finding an alternative substrate with lesser sensitivity. 
 
4.6 References 




   
2. De Laat W, Duboule D. (2013) Topology of mammalian developmental enhancers and 
their regulatory landscapes. Nature; 502: 499–506. 
3. Garcia-Perez JL et al. (2010) Epigenetic silencing of engineered L1 retrotransposition 
events in human embryonic carcinoma cells. Nature; 466: 769-773. 
4. Levine M. (2010) Transcriptional enhancers in animal development and evolution. Curr. 
Biol. ;20: R754–63. 
5. Muotri AR et al. (2005) Somatic mosaicism in neuronal precursor cells mediated by L1 
retrotransposition. Nature; 435: 903-910. 
6. Saha PS and An W. (2019) Recently Mobilised Transposons in the Human Genome. In: 




















   
Chapter 5 
General discussion and future directions 
 
In this project, we successfully characterized a few critical aspects of the LINE-1 promoter 
activity in our transgenic mouse model. We attempted to take a deep insight into the 
determinant factors, which would alter promoter activity in the various situation with 
regards to transgenic expression. 
First, we were able to show that each integration site for the transgene brought about a 
distinct change of promoter activity either as stable or silencing. This position effect 
confirms the critical importance of the site of integration on the level of LINE-1 promoter 
activity. Surprisingly enough, this position effect, again, in turn, can be governed by 
changing the orientation of the cassette. This phenomenon could let us understand why 
some individuals are more susceptible to LINE-1 mediated disorder, while some are 
unaffected. In other words, this locus and orientation-dependent expression pattern also let 
us agree that permissiveness of loci and their transcriptional influence on the LINE-1 
promoter can possess a risk for some LINE-1 medicated diseases. Therefore, evaluating 
locus-specific permissiveness can be a better biomarker than carrying out the same to 
assess global LINE-1 expression or methylation status. 
Second, through our endeavor, it was possible to understand that some organs have no, low 
or high LINE-1 promoter activity – of course depending on the age of the host. To our best 
knowledge, this was the first approach of this kind to understand the in vivo organ-specific 
regulation with considering development-time a factor. The same technique can be 
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diversified to more number of organs of this mouse model; thus, we could get better organ-
specific information. In addition, RNA and protein detection approaches can be included 
to validate our staining data. Studying the promoter activity in cancer/other disease model 
would be helpful to broaden our perspectives on the regulation of the LINE-1 activities in 
respective conditions. 
Third, our current knowledge regarding the cell-types holding the retrotransposition events 
is limited. Still, it is also unknown when cells lose control to repress these “molecular 
parasites” in them and when they cannot.  The attempt of understanding cell-specific 
regulation to the LINE-1 promoter activity can be continued. It might give us an insight 
into how the diverse population of different cell types, not only in the brain but elsewhere 
in the organ system can promote or repress LINE-1 activity.  
The technique relies on a very simple staining technique. It is very handy and cost-
effective, and also can be adopted by any laboratory in a short period. The effect of various 
physiological, pathological, chemical, or environmental factors on LINE-1 mobilization 
can be assayed. For example, the effect of different carcinogens or potential drug 
candidates can be screened for their roles in triggering or barring retrotransposition. It is 
strongly believed that with the help of our technique and mouse model in combination, a 
wide range of chemicals can be assessed within a short time.    
Overall remark regarding this study is, this study may carry consistency with the previous 
ground-breaking works by Brouha et al., 2003, Pizarro and Cristofari, 2016 and finally, 
Philippe et al., 2016 (Brouha et al., 2003; Pizarro and Cristofari, 2016; Philippe et al., 
2016). Although these works are strong in their context; however, they all commonly cross-
talked about the locus-dependency with retrotransposition-competency. Here, we showed 
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in situ that indeed there is a locus-dependency - complicated by age, organ and orientation 
factors - for LINE-1 to be expressed in mammals. 
5.1 References 
1. Brouha B, Schustak J, Badge RM, Lutz-Prigge S, Farley AH, Moran JV, Kazazian HH. 
(2003) Hot L1s account for the bulk of retrotransposition in the human population. 
Proceedings of the National Academy of Sciences of the United States of America 
100:5280–5285. 
2. Philippe C, Vargas-Landin DB, Doucet AJ, van Essen D, Vera-Otarola J, Kuciak M, 
Corbin A, Nigumann P, Cristofari G.  (2016) Activation of individual L1 retrotransposon 
instances is restricted to cell-type dependent permissive loci. Elife; 5. pi: e13926. doi: 
10.7554/eLife.13926. 
3. Pizarro JG, Cristofari G. (2016) Post-Transcriptional Control of LINE-1 Retrotransposition 
by Cellular Host Factors in Somatic Cells. Frontiers in Cell and Developmental Biology 
4:14. 
 
 
 
 
 
 
 
 
 
 
 
------------ 
